US20050214263A1 - Methods and means for gene silencing in plants - Google Patents
Methods and means for gene silencing in plants Download PDFInfo
- Publication number
- US20050214263A1 US20050214263A1 US10/498,660 US49866005A US2005214263A1 US 20050214263 A1 US20050214263 A1 US 20050214263A1 US 49866005 A US49866005 A US 49866005A US 2005214263 A1 US2005214263 A1 US 2005214263A1
- Authority
- US
- United States
- Prior art keywords
- plant
- target gene
- transgene
- silencing
- construct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 105
- 230000030279 gene silencing Effects 0.000 title claims abstract description 92
- 238000012226 gene silencing method Methods 0.000 title description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 163
- 108700019146 Transgenes Proteins 0.000 claims abstract description 125
- 230000014509 gene expression Effects 0.000 claims abstract description 50
- 239000002773 nucleotide Substances 0.000 claims abstract description 39
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 39
- 230000032361 posttranscriptional gene silencing Effects 0.000 claims abstract description 36
- 230000000977 initiatory effect Effects 0.000 claims abstract description 25
- 108020004414 DNA Proteins 0.000 claims abstract description 14
- 108020004511 Recombinant DNA Proteins 0.000 claims abstract description 8
- 230000001131 transforming effect Effects 0.000 claims abstract description 8
- 210000004027 cell Anatomy 0.000 claims description 52
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 47
- 230000008685 targeting Effects 0.000 claims description 35
- 230000009466 transformation Effects 0.000 claims description 31
- 238000013518 transcription Methods 0.000 claims description 28
- 230000035897 transcription Effects 0.000 claims description 28
- 230000001939 inductive effect Effects 0.000 claims description 24
- 102000039446 nucleic acids Human genes 0.000 claims description 19
- 108020004707 nucleic acids Proteins 0.000 claims description 19
- 150000007523 nucleic acids Chemical class 0.000 claims description 19
- 241000700605 Viruses Species 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 16
- 230000009261 transgenic effect Effects 0.000 claims description 15
- 239000002299 complementary DNA Substances 0.000 claims description 9
- 108020004705 Codon Proteins 0.000 claims description 7
- 238000011161 development Methods 0.000 claims description 6
- 210000000805 cytoplasm Anatomy 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 230000006798 recombination Effects 0.000 claims description 2
- 238000005215 recombination Methods 0.000 claims description 2
- 230000001172 regenerating effect Effects 0.000 claims 4
- 238000003892 spreading Methods 0.000 abstract description 67
- 230000007480 spreading Effects 0.000 abstract description 67
- 239000000463 material Substances 0.000 abstract description 8
- 230000002068 genetic effect Effects 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 description 202
- 241000723573 Tobacco rattle virus Species 0.000 description 125
- 241000709992 Potato virus X Species 0.000 description 67
- 239000013598 vector Substances 0.000 description 43
- 239000012634 fragment Substances 0.000 description 41
- 230000009368 gene silencing by RNA Effects 0.000 description 31
- 108020004459 Small interfering RNA Proteins 0.000 description 30
- 108010001545 phytoene dehydrogenase Proteins 0.000 description 29
- 230000000875 corresponding effect Effects 0.000 description 24
- 238000004458 analytical method Methods 0.000 description 23
- 230000007067 DNA methylation Effects 0.000 description 19
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 18
- 230000028604 virus induced gene silencing Effects 0.000 description 18
- 108091093088 Amplicon Proteins 0.000 description 17
- 241000589158 Agrobacterium Species 0.000 description 16
- 239000002609 medium Substances 0.000 description 16
- 241000207746 Nicotiana benthamiana Species 0.000 description 15
- 239000000523 sample Substances 0.000 description 15
- 101100301219 Arabidopsis thaliana RDR6 gene Proteins 0.000 description 14
- 240000007594 Oryza sativa Species 0.000 description 14
- 239000003999 initiator Substances 0.000 description 14
- 235000007164 Oryza sativa Nutrition 0.000 description 13
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 13
- 239000005864 Sulphur Substances 0.000 description 12
- 230000011987 methylation Effects 0.000 description 12
- 238000007069 methylation reaction Methods 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 11
- 238000012423 maintenance Methods 0.000 description 11
- 235000009566 rice Nutrition 0.000 description 11
- 230000019113 chromatin silencing Effects 0.000 description 10
- 230000029087 digestion Effects 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 10
- 238000012033 transcriptional gene silencing Methods 0.000 description 10
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 9
- 238000010276 construction Methods 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 230000000692 anti-sense effect Effects 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 8
- 101100288095 Klebsiella pneumoniae neo gene Proteins 0.000 description 7
- 230000002103 transcriptional effect Effects 0.000 description 7
- 241000219194 Arabidopsis Species 0.000 description 6
- 108020000999 Viral RNA Proteins 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 6
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 6
- 229960005542 ethidium bromide Drugs 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 230000009885 systemic effect Effects 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 108020005544 Antisense RNA Proteins 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 5
- 206010020649 Hyperkeratosis Diseases 0.000 description 5
- 238000000636 Northern blotting Methods 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 108020004518 RNA Probes Proteins 0.000 description 5
- 239000003391 RNA probe Substances 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 230000001960 triggered effect Effects 0.000 description 5
- 230000003612 virological effect Effects 0.000 description 5
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 4
- 108060004795 Methyltransferase Proteins 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229930002875 chlorophyll Natural products 0.000 description 4
- 235000019804 chlorophyll Nutrition 0.000 description 4
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000000411 inducer Substances 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 235000009973 maize Nutrition 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 3
- 101710132601 Capsid protein Proteins 0.000 description 3
- 101710094648 Coat protein Proteins 0.000 description 3
- 101150066002 GFP gene Proteins 0.000 description 3
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 3
- 241000209510 Liliopsida Species 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- 101710125418 Major capsid protein Proteins 0.000 description 3
- 101710141454 Nucleoprotein Proteins 0.000 description 3
- 101150108119 PDS gene Proteins 0.000 description 3
- 101000714429 Potato virus X Coat protein Proteins 0.000 description 3
- 101710083689 Probable capsid protein Proteins 0.000 description 3
- 239000013614 RNA sample Substances 0.000 description 3
- 240000003768 Solanum lycopersicum Species 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- LMSDCGXQALIMLM-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;iron Chemical compound [Fe].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O LMSDCGXQALIMLM-UHFFFAOYSA-N 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 101100367123 Caenorhabditis elegans sul-1 gene Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 108091030087 Initiator element Proteins 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 101150103518 bar gene Proteins 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 108091036078 conserved sequence Proteins 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 230000000408 embryogenic effect Effects 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000011331 genomic analysis Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 101150054900 gus gene Proteins 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 108010086470 magnesium chelatase Proteins 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940027257 timentin Drugs 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 101150106774 9 gene Proteins 0.000 description 1
- 241000023308 Acca Species 0.000 description 1
- 241000282979 Alces alces Species 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 101100532813 Arabidopsis thaliana SDE3 gene Proteins 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 241000195597 Chlamydomonas reinhardtii Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 240000006740 Cichorium endivia Species 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 240000006497 Dianthus caryophyllus Species 0.000 description 1
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 241000702463 Geminiviridae Species 0.000 description 1
- 241000208150 Geraniaceae Species 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 101000962469 Homo sapiens Transcription factor MafF Proteins 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000221961 Neurospora crassa Species 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108091093105 Nuclear DNA Proteins 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 108020005120 Plant DNA Proteins 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 102000000574 RNA-Induced Silencing Complex Human genes 0.000 description 1
- 108010016790 RNA-Induced Silencing Complex Proteins 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 101100512783 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MEH1 gene Proteins 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 108091027544 Subgenomic mRNA Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 102100039187 Transcription factor MafF Human genes 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- JUGOREOARAHOCO-UHFFFAOYSA-M acetylcholine chloride Chemical compound [Cl-].CC(=O)OCC[N+](C)(C)C JUGOREOARAHOCO-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229940098164 augmentin Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000003733 chicria Nutrition 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000034373 developmental growth involved in morphogenesis Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 208000016861 hereditary angioedema type 3 Diseases 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 238000012809 post-inoculation Methods 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
Definitions
- the present invention relates generally to gene silencing methods and materials employing recombinant gene constructs.
- RNA silencing is a nucleotide sequence-specific process of RNA degradation in higher plants (post-transcriptional gene silencing, PTGS), animals (RNA interference, RNAi) and fungi (quelling) as well as in unicellular eukaryotic algae (Carthew, 2001; Matzke et al., 2001; Waterhouse et al., 2001).
- RNA silencing is to protect against viruses (Al-Kaff et al., 1998; Covey et al., 1997; Hamilton and Baulcombe, 1999; Ratcliff et al., 1997).
- a role in genome protection is also likely because there is enhanced transposon mobility in RNA silencing-defective mutants of C.
- Double-stranded RNA is a potent activator of RNA silencing (Fire et al., 1998). Consequently RNA silencing is activated by viral RNAs that replicate via double-stranded intermediates and by transgenes with inverted repeat (IR) structures that could be transcribed into dsRNA (Chuang and Meyerowitz, 2000; Smith et al., 2000; Waterhouse et al., 2001). Single-copy transgenes without IR structures can also activate RNA silencing (Elmayan and Vaucheret, 1996).
- dsRNA single-stranded RNAs
- RdRP RNA-dependent RNA polymerase
- putative RdRPs encoded by the SDE1/SGS2, QDE1 and EGO1 loci are required for RNA silencing in A. thaliana, N. crassa and C. elegans , respectively (Cogoni and Macino, 2000; Dalmay et al., 2000b; Mourrain et al., 2000; Smardon et al., 2000).
- RNA silencing in D. melagonaster have shown that an RNaseIII (DICER) cleaves the dsRNAs into 21-25 nucleotide RNAs short interfering RNAs (siRNAs) that associate with a second RNase in an ‘RNA-induced silencing complex’ (RISC) (Bernstein et al., 2001; Hammond et al., 2000). RISC cleaves target single-stranded RNAs at a site that is complementary to the (antisense) siRNA.
- RISC RNA-induced silencing complex
- the role of the siRNAs is to provide sequence-specificity to RNA silencing (Elbashir et al., 2001). Plant DICER and RISC have not yet been identified. However, siRNAs are present in plant RNA silencing systems suggesting that mechanisms are conserved across kingdoms (Hamilton and Baulcombe, 1999).
- viruses carrying portions of host genes can initiate silencing of the corresponding RNA through a process known as virus-induced gene silencing (VIGS) (Kumagai et al., 1995; Ruiz et al., 1998).
- VIGS virus-induced gene silencing
- the target sequence is from a transgene
- the viral RNA is eventually eliminated by the silencing process.
- the transgene remains silenced.
- VIGS of transgenes is associated with sequence-specific methylation of transgene DNA (Jones et al., 1999). This process, termed RNA-directed DNA methylation (RdDM), is a consequence of dsRNA or siRNAs interacting directly with the target DNA (Wassenegger, 2000).
- initiation and maintenance phases of the RNA silencing mechanism referred to as initiation and maintenance (Ruiz et al., 1998). Consistent with this idea it was shown in Arabidopsis that the two phases could be differentiated by mutation analysis and by the methylation of a GFP transgene. In wild-type plants there is both initiation and maintenance of GFP silencing and RdDM of the GFP transgene. In contrast in sde1/sgs2 and sde3 mutants there is initiation but not maintenance and the transgene is not methylated (Dalmay et al., 2001).
- RNA silencing of the transgenes is triggered by delivery of ectopic DNA via Agrobacterium infiltration, by bombardment or in grafting experiments (Palauqui and Balzergue, 1999; Palauqui et al., 1997; Voinnet and Baulcombe, 1997; Voinnet et al., 1998).
- localized initiation of RNA silencing triggers systemic silencing throughout the plant.
- systemic silencing is maintained even if the region in which silencing is initiated is removed.
- the present inventors provide herein novel but powerful systems which have utility inter alia for silencing of endogenous genes.
- the inventors closely investigated the maintenance phase of RNA silencing and its association with spreading of both targeting and DNA methylation (as used herein, the term “spreading” is used to describe a molecular process rather than the systemic movement of a silencing signal).
- spreading is used to describe a molecular process rather than the systemic movement of a silencing signal.
- all parts of a targeted transcript are targets of RNA silencing even if the dsRNA initiator sequence corresponds to only a fragment of it.
- the inventors have demonstrated inter alia that spreading and maintenance are closely associated, both seemingly being dependent on a putative RdRP. They have also demonstrated that spreading requires transcription of the target RNA. Combined these data support a model of RNA silencing in which spreading of targeting and maintenance involve production of dsRNA by an RdRP using the target sense RNA as a template.
- the inventors herein provide methods and materials utilising spreading in trans which in preferred embodiments may be used to provide consistent, maintained, silencing of endogenous genes, optionally in a conditional matter.
- No such spreading-based systems were disclosed in the prior art, and they have utility inter alia for functional genomics.
- the spreading-based system facilitates gene-function studies e.g. in A. thaliana.
- Results shown herein demonstrate that it is possible to use spreading as a technology for silencing endogenes e.g. using a viral amplicon as inducer of silencing of transgene-endogene chimeras.
- Spreading can take place either from only one direction (3′ to 5′) or in both directions.
- the length of the homologous sequences can be relatively short.
- the systems of the present invention for silencing target sequences are based on two elements (i) an initiator element which can serve to initiate gene silencing in an organism against an appropriate sequence, such as a transgene sequence, and (ii) a receptor element which includes an element which can be silenced by the initiator construct (e.g. a transgene which is identical to all or part of that initiator element) plus also a sequence identical to the intended target of silencing.
- the two receptor elements are present in the organism in the same genetic background e.g. introduced therein by transformation with a DNA construct.
- the elements may be provided by a “triggering construct” which provides the dsRNA to initiate or trigger RNA silencing, and a “spreading construct” which carries a chimeric gene composed of a portion of the triggering construct plus sequence from an endogenous cDNA.
- a “triggering construct” which provides the dsRNA to initiate or trigger RNA silencing
- a “spreading construct” which carries a chimeric gene composed of a portion of the triggering construct plus sequence from an endogenous cDNA.
- a method of silencing a target gene in an organism comprises the steps of:
- steps (a) ⁇ (b) and (c) may be performed in any order i.e. the PTGS of the transgene may be initiated or extant in the organism prior to provision, introduction, or transformation of the chimeric nucleotide sequence.
- “Silencing” is a term generally used to refer to suppression of expression of a gene (generally by PTGS). The degree of reduction may be so as to totally abolish production of the encoded gene product, but may also be such that the abolition of expression is not complete, with some small degree of expression remaining. The term should not therefore be taken to require complete “silencing” of expression. It is used herein where convenient because those skilled in the art well understand this. In preferred embodiments the silencing will be maintained even if the initiator of the PTGS of the transgene is removed.
- Gene used broadly coding sequence in the DNA genome of an organism which is, or may be, expressed via transcription to mRNA and translation to a protein according to well established principles. It will generally be an endogenous gene of the organism. Preferred target genes are discussed below.
- the “transgene” is foreign (non-native) to the organism, which is to say that it does not occur naturally in the organism's genome.
- the “initiation” of silencing of the transgene may be by a variety of methods which are discussed in more detail hereinafter. Generally it may comprise the step of introducing into the organism a further nucleic acid construct which includes sequence corresponding to the transgene sequence such as to initiate PTGS of the transgene. As stated above, the (silenced) transgene may already be present in the organism prior to the introduction of chimeric sequence.
- the method may further include the step of causing or permitting transcription from the promoter such as to produce an mRNA transcript of the expression cassette.
- Nucleic acid constructs according to the present invention will be recombinant and may be provided isolated and/or purified, in substantially pure or homogeneous form, or free or substantially free of other nucleic acid.
- isolated encompasses all these possibilities.
- nucleic acid may be double stranded, where nucleic acid (or nucleotide sequence) of the invention is referred to herein, use of the complement of that nucleic acid (or nucleotide sequence) will also be embraced by the invention.
- the ‘complement’ in each case is the same length as the reference, but is 100% complementary thereto whereby by each nucleotide is base paired to its counterpart i.e. G to C, and A to T or U.
- vectors may include, in addition to the promoter, a suitable terminator or other regulatory sequence such as to define an expression cassette comprising the chimeric sequence.
- an additional optional feature of a construct used in accordance with the present invention is a transcriptional terminator.
- a transcriptional terminator from nopaline synthase (nos) gene of agrobacterium tumefaciens (Depicker, A., et al (1982), J. Mol. Appl. Genet., 1: 561-573) may be used.
- Other suitable transcriptional terminators will be well known to those skilled in the art.
- the expression cassette will generally be situated between border sequences and are capable of being inserted into a plant genome under appropriate conditions. Generally this may be achieved by use of so called “agro-infiltration” which uses Agrobacterium -mediated transformation. Briefly, this technique is based on the property of Agrobacterium tumafaciens to transfer a portion of its DNA (“T-DNA”) into a host cell where it may become integrated into nuclear DNA.
- T-DNA is defined by left and right border sequences which are around 25 nucleotides in length.
- the border sequences are included around the transfer nucleotide sequence (the T-DNA) with the whole vector being introduced into the plant by agro-infiltration, optionally in the form of a binary-transformation vector.
- the construct may include border sequences which permit the transfer of the transfer nucleotide sequence into a plant cell nucleus. Methods are described in more detail in the Examples hereinafter.
- aspects of the present invention include the isolated recombinant DNA construct described above. Also provided is a composition comprising a plurality of said constructs, each including a separate target gene (preferably from the same organism). Also provided are kits comprising one or more said constructs, and their use in the methods described herein.
- promoter is meant a sequence of nucleotides from which transcription may be initiated of DNA operably linked downstream (i.e. in the 3′ direction on the sense strand of double-stranded DNA). “Operably linked” means joined as part of the same nucleic acid molecule, suitably positioned and oriented for transcription to be initiated from the promoter. Nucleic acid operably linked to a promoter is “under transcriptional initiation regulation” of the promoter.
- the promoter may be inducible.
- inducible as applied to a promoter is well understood by those skilled in the art. In essence, expression under the control of an inducible promoter is “switched on” or increased in response to an applied stimulus. The nature of the stimulus varies between promoters. Some inducible promoters cause little or undetectable levels of expression (or no expression) in the absence of the appropriate stimulus. Other inducible promoters cause detectable constitutive expression in the absence of the stimulus. Whatever the level of expression is in the absence of the stimulus, expression from any inducible promoter is increased in the presence of the correct stimulus.
- both “trigger” and “spreading” constructs are placed under individual inducible promoters such as to permit the triggering of silencing at different times and conditions.
- Suitable plant active promoters will be well known to those skilled in the art.
- Preferred promoters may include the 35S promoter of cauliflower mosaic virus or the nopaline synthase promoter of Agrobacterium tumefaciens (Sanders, P. R., et al (1987), Nucleic Acids Res., 15: 1543-1558). These promoters are expressed in many, if not all, cell types of many plants.
- the construct may incorporate a promoter that is be activated specifically by that stimulus. Promoters that are both tissue specific and inducible by specific stimuli may be used.
- Suitable promoters may include the maize glutathione-S-transferase isoform II (GST-II-27) gene promoter which is activated in response to application of exogenous safener (WO93/01294, ICI Ltd).
- GST-II-27 maize glutathione-S-transferase isoform II
- Another suitable (preferred) promoter may be the DEX promoter (Plant Journal (1997) 11: 605-612).
- the chimeric sequence will include all or part of the target gene and the transgene.
- the transgene is GFP or GUS, although (as shown in the examples) it could even be a viral fragment or an exogenous sequence inserted into the viral genome, such as GFP in PVX/GFP amplicon.
- the part of the target gene will include more than just the promoter of the target gene, and will preferably include at least the initiating ATG codon of the target gene. It may optionally include all or part of the terminator.
- sequences need not run intact contiguously.
- the target gene may be inserted within the transgene, as in the Examples below. Provided they are ultimately present in the same genetic background, they need not form part of a single ORF.
- a targeting sequence employed in a construct in accordance with the present invention may be a wild-type sequence (e.g.
- a typical construct may include a sequence wherein the targeting sequence and the sequence within the target gene are substantially homologous, by which is meant that the sequence in question shares at least about 70%, or 80% identity, most preferably at least about 90%, 95%, 96%, 97%, 98% or 99% identity with the reference sequence.
- the sequence will preferably be at least 21, 22, 23, 24, or 25 nucleotides in length. It may be longer e.g. at least 200 nt or 745 nt.
- Identity may be at the nucleotide sequence and/or encoded amino acid sequence level. Homology may be over the full-length of the relevant sequence shown herein (e.g. in the sequence Annex) or may be over a part of it. Identity may be determined by the TBLASTN program, of Altschul et al. (1990) J. Mol. Biol. 215: 403-10, or BestFit, which is part of the Wisconsin Package, Version 8, September 1994, (Genetics Computer Group, 575 Science Drive, Madison, Wis., USA, Wisconsin 53711). Preferably sequence comparisons are made using FASTA and FASTP (see Pearson & Lipman, 1988. Methods in Enzymology 183: 63-98).
- Parameters are preferably set, using the default matrix, as follows: Gapopen (penalty for the first residue in a gap): ⁇ 12 for proteins/ ⁇ 16 for DNA; Gapext (penalty for additional residues in a gap): ⁇ 2 for proteins/ ⁇ 4 for DNA; KTUP word length: 2 for proteins/6 for DNA.
- Preferred target genes may include those which confer ‘unwanted’ traits in the plant and which it may therefore be desired to silence. Examples include ripening specific genes in tomato to improve processing and handling characteristics of the harvested fruit; genes involved in pollen formation so that breeders can reproducibly generate male sterile plants for the production of F1 hybrids; genes involved in lignin biosynthesis to improve the quality of paper pulp made from vegetative tissue of the plant; gene silencing of genes involved in flower pigment production to produce novel flower colours; gene silencing of genes involved in regulatory pathways controlling development or environmental responses to produce plants with novel growth habit or (for example) disease resistance; elimination of toxic secondary metabolites by gene silencing of genes required for toxin production.
- a further possibility is to target a conserved sequence of a gene, e.g. a sequence that is characteristic of one or more genes in one or more pathogens against which resistance is desired, such as a regulatory sequence.
- a construct may target a conserved sequence within a target gene group such as to down-regulate expression of one or more members of a target gene group. More than one targeting sequence may be included.
- the initial silencing step may be achieved by any conventional method appropriate to the organism in question. This then spreads in trans to the target gene.
- initiation of PTGS of said transgene in the organism may be achieved by introducing a virus (or sequence derived therefrom) including all or part of the transgene sequence.
- VIGS vectors include those based on PVX, TRV, TMV and geminiviruses (Kumagai et al., 1995; Kjemtrup et al., 1998; Ruiz et al., 1998; Peele et al., 2001; Ratcliff et al., 2001)
- a method of silencing a target gene in an organism comprises the steps of:
- the invention provides a method of silencing a target gene in an organism, which method comprises the steps of:
- the invention is performed (i.e. the DNA construct is used) in order to silence a target endogenous gene in a plant which is transformed with said construct.
- the invention is applicable to both monocot and dicot plants.
- a method of silencing a target gene in an organism comprises the steps of:
- the present invention may be used in plants such as crop plants, including cereals and pulses, maize, wheat, potatoes, tapioca, rice, sorgum, millet, cassaya, barley, pea and other root, tuber or seed crops.
- Important seed crops are oil seed rape, sugar beet, maize, sunflower, soybean and sorghum.
- Horticultural plants to which the present invention may be applied may include lettuce, endive and vegetable brassicas including cabbage, broccoli and cauliflower, and carnations and geraniums.
- the present invention may be applied to tobacco, cucurbits, carrot, strawberry, sunflower, tomato, pepper, chrysanthemum, poplar, eucalyptus and pine.
- Nicotiana benthamiana For genomic analysis (see below), it may be preferred to use Nicotiana benthamiana, Arabidopsis thaliana or Oryza sativa.
- Any appropriate method of plant transformation may be used to generate plant cells containing a construct within the genome in accordance with the present invention. Following transformation, plants may be regenerated from transformed plant cells and tissue. Successfully transformed cells and/or plants, i.e. with the construct incorporated into their genome, may be selected following introduction of the nucleic acid into plant cells, optionally followed by regeneration into a plant, e.g. using one or more marker genes such as antibiotic resistance.
- transgene-silencing constructs e.g. amplicon
- Plants transformed with the DNA construct may be produced by standard techniques which are already known for the genetic manipulation of plants.
- DNA can be transformed into plant cells using any suitable technology, such as a disarmed Ti-plasmid vector carried by Agrobacterium exploiting its natural gene transfer ability (EP-A-270355, EP-A-0116718, NAR 12(22) 8711-87215 1984), particle or microprojectile bombardment (U.S. Pat. No. 5,100,792, EP-A-444882, EP-A-434616) microinjection (WO 92/09696, WO 94/00583, EP 331083, EP 175966, Green et al.
- a disarmed Ti-plasmid vector carried by Agrobacterium exploiting its natural gene transfer ability (EP-A-270355, EP-A-0116718, NAR 12(22) 8711-87215 1984), particle or microprojectile bombardment (U.S. Pat. No. 5,100,792, EP-A-444882, EP-A-434616)
- Agrobacterium transformation is widely used by those skilled in the art to transform dicotyledonous species.
- Production of stable, fertile monocot transgenic plants may be achieved e.g. using the techniques of, or analogous to, Toriyama, et al. (1988) Bio/Technology 6, 1072-1074; Zhang, et al. (1988) Plant Cell Rep. 7, 379-384; Zhang, et al. (1988) Theor Appl Genet 76, 835-840; Shimamoto, et al. (1989) Nature 338, 274-276; Datta, et al. (1990) Bio/Technology 8, 736-740; Christou, et al.
- Microprojectile bombardment, electroporation and direct DNA uptake are preferred where Agrobacterium is inefficient or ineffective.
- a combination of different techniques may be employed to enhance the efficiency of the transformation process, eg bombardment with Agrobacterium coated microparticles (EP-A-486234) or microprojectile bombardment to induce wounding followed by co-cultivation with Agrobacterium (EP-A-486233).
- a plant may be regenerated, e.g. from single cells, callus tissue or leaf discs, as is standard in the art. Almost any plant can be entirely regenerated from cells, tissues and organs of the plant. Available techniques are reviewd in Vasil et al., Cell Culture and Somatic Cel Genetics of Plants, Vol I, II and III, Laboratory Procedures and Their Applications , Academic Press, 1984, and Weissbach and Weissbach, Methods for Plant Molecular Biology , Academic Press, 1989.
- a host cell including, or transformed by, the DNA construct according to the present invention.
- Use of the construct as described above in the transformation (stable or transient) of a plant is also embraced by the invention.
- the host cell will preferably have incorporated into its genome a construct as described above (i.e. be transformed by it).
- a further aspect of the present invention provides a method of making such a plant cell involving introduction of a vector including the construct into a plant cell. Such introduction should be followed by recombination between the vector and the plant cell genome to introduce the sequence of nucleotides into the genome.
- RNA encoded by the introduced nucleic acid construct may then be transcribed in the cell and descendants thereof, including cells in plants regenerated from transformed material.
- a gene stably incorporated into the genome of a plant is passed from generation to generation to descendants of the plant, so such descendants should show the desired phenotype.
- the present invention also provides a plant comprising a plant cell as disclosed.
- the present invention provides any clone of such a plant, seed, selfed or hybrid progeny and descendants, and any part of any of these, such as cuttings, seed.
- a further aspect of the present invention provides a method of reducing or suppressing or lowering the level of a target gene in a plant cell, the method including causing or allowing transcription from the construct as disclosed above.
- the present invention is concerned with providing silencing-based methods are useful in functional genomics.
- the target gene may be of unknown phenotype, in which case the system may be employed to analyse the phenotype by generating a widespread null (or nearly null) phenotype.
- the target gene may be essential, which is to say that the null phenotype is lethal to the cell or tissue in question.
- plants are first transformed with a single type of “triggering construct” (e.g. based on an inducible promoter and Amplicon or IR as described above). After that point only simple high throughput cloning steps are needed.
- a cDNA (or other) library can be cloned into a corresponding “spreading construct”. This library is then used for large scale plant transformations in order to generate an extensive collection of transformant plants. Following induction of the triggering construct, and due to the dominant character of RNA silencing, these plants can be immediately screened for specific null-phenotypes.
- the silenced gene sequences of interest in the phenotypes can be PCR-amplified easily by using primers specific to the spreading construct (and in particular the portion therein in which the library insert is introduced).
- This system provides an excellent inducible and dominant null-phenotype generating machine for high throughput forward genetic studies in A. thaliana.
- the antisense siRNAs needed to target endogenous mRNA will be produced independently of the orientation of the endogenous cDNA in the spreading construct. This further facilitates the cloning steps.
- the silencing is initiated using an inducible promoter e.g. applying an exogenous inducer to cause transcription of the triggering construct at an appropriate time.
- the phenotype is then observed.
- the observation will be contrasted with a plant wherein the target gene is being expressed in order to characterise (i.e. establish one or more phenotypic characteristics of) the gene.
- a method of altering the phenotype of a plant comprising use of the silencing method discussed above.
- Traits for which it may be desirable to change the phenotype include the following: colour; disease or pest resistance; ripening potential; male sterility etc.
- the methods of the present invention may be followed by assessing the silencing of the target gene.
- Detection may be using any method known in the art or described herein. Detection may be by analysis of siRNAs and may involve the steps of:
- sample may be all or part of the organism, but will include at least some cellular material.
- FIGURES SEQUENCE APPENDIX AND EXAMPLES
- FIG. 1 Spreading of targeting on a GFP transgene.
- FIG. 1 Schematic representation of the experimental procedure. Post-transcriptional gene silencing (PTGS) of a 35S:GFP:NOS transgene in N. benthamiana plants (line 16c) was triggered by inoculating with TRV carrying a region of the GFP sequence. Subsequently plants were challenge-inoculated with PVX carrying another region of the GFP transgene and resistance was assessed. Plants infected with TRV:00 or TRV:35S were used as non-PTGS controls.
- Sense RNA probes were specific for antisense RNAs corresponding to the P region of GFP (top panel) or TRV (bottom panel).
- FIG. 2 Spreading of targeting on a GFP/PDS chimeric gene.
- FIG. 1 Schematic representation of the GFP/PDS chimeric transgene including the 35S promoter, the GFP sequences and the PDS region.
- B GFP/PDS chimeric plants (line #D) inoculated with TRV:00, or TRV:GF photographed at 21 dpi.
- C Analysis of siRNAs (21/25 nucleotide in length) from TRV:GF- or TRV:PD-infected at 21 dpi. Sense RNA probes were specific for antisense RNAs corresponding to the GF region of GFP (top panel) or PD of the PDS (bottom panel).
- FIG. 3 Spreading requires transgene transcription.
- TGS Transcriptional gene silencing
- N. benthamiana line 16c
- TRV:35S-infection Following the onset of TGS, plants were inoculated with PVX carrying a region of the GFP transgene and siRNAs and DNA methylation corresponding to the rest of the GFP sequence were assessed. Plants infected with TRV:00 were used as a non-TGS control.
- B Analysis of siRNAs (21/25 nucleotide in length) from non-TGS (TRV:00) or TGS (TRV:35S) plants infected with PVX:GF or PVX:P.
- RNA samples were extracted from upper leaves at 21 days post-PVX infection. At this time point TRV:00-infected control plants were showing full GFP silencing by PVX:GF or PVX:P. Sense RNA probes were specific for antisense RNAs corresponding to the GF or P regions of GFP (top and bottom panel respectively).
- C and D Analysis of DNA methylation within GF and P regions by Sau96I digestion followed by quantitative PCR.
- DNA samples were prepared from non-TGS (TRV:00) (C) or TGS (TRV:35S) (D) plants infected with PVX:00, PVX:GF or PVX:P at 21 dpi.
- Amplification values represent the degree of DNA methylation. Values are the average of three independent experiments. The values represent the DNA methylation level: the higher the amplification value, the greater the degree of DNA methylation in the PCR template.
- FIG. 4 Spreading requires SDE1SGS2.
- Sense RNA probes were specific for antisense RNAs corresponding to the GF or P regions of GFP (low and top panel respectively).
- C Schematic map of the 35S:GFP:NOS transgene in A. thaliana . Expected sizes (in kb) for total and relevant partial Sau96I restriction enzyme digestions and the P probe used for Southern analysis are indicated.
- D Southern blot analysis of Sau96I digested DNA extracted from pooled plants as described in (A). Sizes of relevant DNA fragments are indicated. Bands marked with an asterisk are due to a low level of methylation at the Sau96I site within the 35S promoter.
- FIG. 5 Spreading and endogenes.
- FIG. 6 This shows Table 1 listing the sequences of the oligonucleotides used in the Examples.
- FIG. 7 Construction of pGIIGPS.
- L left border of T DNA.
- R right border.
- 35S P 35S promoter.
- 35S T 35 S terminator.
- IVS intron from ST-LS1 gene from potato cloned in GUS. Showed as a black box.
- FIG. 8 Construction of negative control pGIIGS. Abbreviations as in FIG. 7 .
- FIG. 9 Construction of pKIIGPS. Abbreviations as in FIG. 7 .
- FIG. 10 Construction of pGF/FG. ChsA: intron from Chalcone Sintase gene. OCS: octopine synthase 3′ polyadenylation sequence. Xh: XhoI. N: NcoI. As: AscI. Sw: SwaI. B: BamHI. A: AvrII. Xb: XbaI. P: PacI. Xm: XmaI.
- FIG. 11 Construction of pTAdsGF.
- Ind Pro stands for the elements of the inducible promoter.
- 3A T Pea Rubisco small subunit gene terminator.
- the N. benthamiana 16c line and the A. thaliana GFP wild-type and sde1/sgs2 lines were described previously (Dalmay et al., 2000a; Dalmay et al., 2001; Ruiz et al., 1998). Visual observation of GFP fluorescence was performed according to Voinnet et al. (1998).
- the line #D was made as follows: a 600 bp GFP DNA fragment was PCR amplified using oligos GFP1 and GFP6 (see Table 1 for sequences) and cloned into the SmaI-digested pJIT60 vector (www.pgreen.ac.uk).
- KpnI/XhoI fragment was inserted into KpnI/XbaI-digested pGreen0229 binary vector (www.pgreen.ac.uk).
- a 416 bp N. benthamiana PDS cDNA fragment was PCR amplified using oligos PDS-5-AS and PDS-3-AS (see Table 1 for sequences) and cloned in the antisense orientation into the Bst1107I site of GFP.
- the resulting vector was used to obtain transgenic N. benthamiana according to Horsch et al. (Horsch et al., 1985).
- the primers used to PCR amplify the different regions of the GFP:NOS, PDS and rubisco genes are as follows: GFP1 and GFP4 for GF (400 bp), GFP5 and GFP8 for P (332 bp), TNOS1 and TNOS3 for NOS (154 bp), PDS-5-AS and PDS-MID3 for PD (213 bp), PDS-MID5 and PDS-3-AS for S (216 bp), Rub-5-AS and Rud-MID3 for RU (272 bp) and Rub-MID5 and Rub-3-AS for BISCO (250 bp) (see Table 1 for sequences).
- TRV:35S vector was described previously (Jones et al., 2001). TRV inoculations of N. benthamiana have been described previously (Ratcliff et al., 2001). For A.
- thaliana TRV:GF inoculations 7 day old seedlings were vacuum-infiltrated with a pTRV:GF/pBINTRA6 Agrobacterium suspension mix (Ratcliff et al., 2001).
- pPVX:PD and pPVX:S vectors were obtained by cloning the PD and S fragments into the SmaI site of pGR107 (Jones at al., 1999).
- PVX:GF and PVX:P vectors were described previously (Ruiz et al., 1998; Voinnet et al., 1998). PVX inoculations of N. benthamiana were as described in Ruiz et al. (1998), Voinnet et al. (1998) and Jones et al. (1999).
- Genomic DNA was extracted using the DNeasy plant DNA extraction kit (Qiagen) according to the manufacturer's instructions. DNA gel-blot was performed as described previously (Jones et al., 1998). The DNA methylation analysis by Sau96I digestion and Taqman quantitative PCR was performed as described previously (Jones et al., 2001) using DNA prepared from upper leaves. The two oligos and the probe used for the analysis of the GF region were GF-5, GF-3, and GF-probe respectively (see Table 1 for sequences). The oligos and probes used for analysis of the P region and controls were described previously (Jones et al., 2001).
- VIGS of a 35S:GFP:NOS transgene in N. benthamiana (line 16c) (Ruiz et al., 1998) using tobacco rattle virus (TRV) vectors carrying inserts corresponding to different parts of the transgene.
- TRV tobacco rattle virus
- RNA target of VIGS was challenged-inoculating plants with potato virus X (PVX) vectors carrying other parts of the GFP transgene ( FIG. 1A ) and by characterizing the siRNAs associated with silencing of the GFP mRNA. From our previous experiments we anticipated that the PVX RNA would not accumulate if it carries an insert that is target of RNA silencing. Accordingly, there would be accumulation of siRNAs corresponding to the target region of RNA silencing.
- TRV vectors carrying the 5′ or 3′ halves of the GFP coding region or the 3′ untranslated region (TRV:GF, TRV:P and TRV:NOS, respectively).
- TRV:00 As controls, plants were infected with TRV without an insert (TRV:00) or carrying the 35S promoter (TRV:35S).
- TRV:00 would not cause silencing of the transgene whereas TRV:35S would trigger transcriptional silencing of 35S-driven transgenes (Jones et al., 1999; Jones et al., 2001).
- 1C shows that PVX:P accumulated at high levels in TRV:00 and TRV:35S infected plants and at low levels in TRV:GF, TRV:P or TRV:NOS infected plants.
- the ‘P’ region of GFP was a target irrespective of whether the initiator was GF, P or NOS.
- P probe antisense P-specific siRNAs
- GF-siRNAs and NOS-siRNAs were present in samples from TRV:GF-, TRV:P- and TRV:NOS-infected plants but not in those from TRV:00- and in TRV:35S-infected plants (data not shown).
- the siRNA population was distributed throughout the transcribed region of the GFP transgene.
- TRV-siRNAs were detected in all the TRV-infected plants ( FIG. 1D , bottom panel) as expected from the finding that RNA silencing is a natural mechanism for virus resistance in plants (Hamilton and Baulcombe, 1999; Ratcliff et al., 1999).
- RNA silencing can spread within the transcribed regions of the transgene from the initiator region in both 3′ (from GF to P) and 5′ (from NOS to P) directions. Moreover, because NOS-siRNAs were produced following initiation with GF and vice versa, we have shown that spreading can extend further than the 332 bp corresponding to the P region. The presence of antisense siRNAs corresponding to sequences beyond the initiator region indicates that a dsRNA copy of the target has been produced.
- siRNAs corresponding to the PDS region of the chimeric gene may be produced by spreading of targeting from a GFP initiator. These PDS-siRNAs would target the endogenous PDS mRNA and cause photobleaching.
- FIG. 2B shows that TRV:GF but not TRV:00 triggered photobleaching.
- Non-transgenic or 35S:GFP:NOS transgenic plants did not show any PDS silencing after infection with TRV:GF (data not shown).
- Spreading of targeting in line #D was confirmed by analyzing the siRNA population following infection with TRV:GF or TRV:PD which carries a part of the PDS region of the chimeric transgene. Both GF- and PD-siRNAs were present in TRV:GF- or TRV:PD-infected plants but were not in TRV:00-infected plants ( FIG. 2C ). Therefore spreading of targeting in both 5′ and 3′ directions is not specific to the 35S:GFP:NOS transgene in line 16c.
- both GF- and P-siRNAs were produced in TRV:00-infected plants following PVX:GF or PVX:P inoculations.
- the spreading of targeting occurred with a PVX vector as for TRV vectors, and was not affected by the presence of TRV:00.
- TRV:35S-infected plants only P-siRNAs were detected in PVX:P-infected tissue and, likewise, only GF-siRNAs were detected in PVX:GF-infected tissue ( FIG. 3B , top and bottom panels).
- FIG. 3C shows that, after PVX:GF or PVX:P inoculation of TRV:00-infected plants, amplification values for both GF and P sequences were higher than those of the non-methylated negative control (PVX:00-infected plants).
- FIG. 4A shows that, at 10-15 dpi, GFP mRNA levels were lower in silenced plants than in non-silenced mock inoculated plants and that TRV:GF RNA was more abundant in sde1/sgs2 than in the wild-type plants.
- the GF-siRNAs were present in both samples but were more abundant in sde1/sgs2 plants ( FIG. 4B , bottom panel). This increased abundance of GF-siRNA is most likely due to the higher accumulation of TRV:GF in sde1/sgs2 plants ( FIG. 4A ). From these results we conclude that SDE1/SGS2 is not necessary for siRNA production from the TRV:GF RNA.
- the P-siRNAs were detected in the TRV:GF-infected wild-type plants ( FIG. 4B , top-panel) indicating that spreading of targeting takes place in A. thaliana as in N. benthamiana .
- P-siRNAs were not produced in the TRV:GF-infected sde1/sgs2 plants ( FIG. 4B top panel). Therefore spreading of targeting is dependent on SDE1/SGS2.
- FIG. 4C shows the organization of the 35S:GFP:NOS transgene, the location of Sau96I restriction enzyme sites and the sizes of total and relevant partial digestion products of the GFP transgene.
- FIG. 4D shows that, in mock-inoculated plants, only the 0.28 kb fragment (corresponding to the unmethylated DNA) could be detected. The 0.37 kb and 0.08 kb fragments of were most likely not detected because of either the low resolution of the gel or because the P probe overlapping region is too short.
- TRV:GF-infected wild-type plants the Sau96I digestion products were 0.28 kb, 0.84 kb and 1.29 kb.
- the 0.84 kb fragment indicates methylation in the GF region and the 1.29 kb fragment reflects methylation in both GF and P regions.
- the TRV:GF-infected sde1/sgs2 plants the only fragment diagnostic of transgene methylation was 0.84 kb. From these results we conclude that spreading of DNA methylation, like spreading of targeting, is dependent on SDE1/SGS2. Results leading to the same conclusion were also generated with HaeIII digested DNA (data not shown).
- VIGS of PDS and ribulose bisphosphate carboxylase small subunit is unlike that of GFP. This RNA silencing of these endogenous genes is dependent on the continuous presence of the virus and the target DNA is not methylated (Jones et al., 1999; Ruiz et al., 1998; Thomas et al., 2001). Thus, VIGS of PDS and rubisco does not show the transition to the maintenance phase of RNA silencing.
- To assess spreading of targeting in VIGS of PDS we used the same approach as with the 35S:GFP:NOS transgene ( FIG. 1A ). First we initiated VIGS in N. benthamiana with TRV vectors carrying a fragment of the PDS gene. We then challenge-inoculated with PVX carrying a different part of the PDS gene. Spreading of targeting would have caused the plants to be resistant against the challenge inoculum.
- TRV vectors used in these experiments were TRV:PD and TRV:S which carry two contiguous non-overlapping regions of the N. benthamiana PDS cDNA. Plants infected with TRV:00 were used as a control for non-specific effects of virus inoculation. By 21 dpi, PDS silencing was observed as photobleached tissues in plants infected with both TRV:PD and TRV:S. In contrast, plants infected with TRV:00 remained non-silenced ( FIG. 6A ).
- FIG. 6B shows that, in TRV:00-infected plants, both PVX:PD and PVX:S accumulated at high levels. In TRV:PD-infected plants PVX:S accumulated at high levels. In contrast, PVX:PD accumulated at low levels as a consequence of crossprotection (Ratcliff et al., 1997; Ratcliff et al., 1999).
- FIG. 6C shows analogous results from plants infected with TRV:RU and TRV:BISCO carrying contiguous non-overlapping fragments of the rubisco cDNA.
- the construct pGIIGPS carries the whole GUS gene, a fragment of sulphur gene and a fragment of the coat protein (CP) from PVX. Its construction is showed in FIG. 7 .
- the cloning of the different fragments was made in a modified pGreenII 0229 vector (kindly provided by Dr. R. Hellens, JIC, Norwich, UK), which carries a gene that confers resistance to BASTA.
- the polylinker of pGreenII0229 was removed by digestion with SacI, blunt-ended and re-digested with Asp718.
- the polylinker was substituted by the 35S cassette from pJIT61 (kindly provided by P.
- the GUS gene containing an intron from ST-LS1 from potato, was amplified from plasmid pLaw3 using Expand Hi Fi DNA polymerase and the primers F5′GUS (5′TTATGTTACGTCCTGTAGAAACCC), and 3′GUS (5′TCATTGTTTGCCTCCCTGCTGC). The 2000 nt long PCR fragment was blunt ended and cloned into the HindIII blunt-ended site of pGII61 to produce the plasmid pGIIGUS.
- This plasmid was then digested with EcoRI and blunt ended using T4 DNA polymerase and used to clone a fragment of 742 nt from PVX CP generated by digestion of pgR106 (vector for PVX, kindly provided by Lu Rui, The Sainsbury Laboratory, Norwich, UK) with SalI and XhoI and blunt ended, producing the plasmid pGIIGP.
- This plasmid has a polylinker with sites for XbaI, BamHI, SmaI, XmaI and SacI where target genes can be cloned.
- As a target gene for spreading we introduced a fragment of sulphur gene from Arabidopsis (Kjemtrup et al., 1998).
- a 965 bp PCR fragment was amplified using Expand Hi Fi DNA polymerase (Boehringer) and the primers Sul1 (5′ccttggcgcgCCTTCACTCTCTTCTCCTTCC) and Sul2 (5′ccccttaattAATCTGGTCTTGAAGCTTGTCC) where the sequence in upper case corresponds to sulphur and the sequences in lower case introduce restriction site for AscI (Sul1) or PacI (Sul2).
- the fragment was blunt-ended and cloned into the Sac I, blunt ended site of pGIIGP, producing the plasmid pGIIGPS.
- the sulphur gene encodes for a magnesium chelatase involved in chlorophyll production.
- a PCR fragment including the 35S promoter, GUS-IVS gene, Sulphur and PVX CP and 35S terminator was amplified from pGIIGPS and pGIIGS using the primers TR35S (5′ ccatatgtttaaaCCCCTACTCCAAAAATGTC) where the sequence in upper case corresponds to the 35S promoter and TR35T (5′ cccgtagtttaaacgtcgaggatATCGCATGC) where the sequences in upper case correspond to 35S terminator.
- TR35S 5′ ccatatgtttaaaCCCCTACTCCAAAAATGTC
- TR35T 5′ cccgtagtttaaacgtcgaggatATCGCATGC
- PVX/GFP amplicon Arabidopsis plants were transformed either with pKIIGPS or pKIIGS constructs.
- sulphur gene encodes for a magnesium chelatase involved in chlorophyll production, its silencing should produce total or partial yellow plants.
- Seeds from primary transformation were germinated in plates with GM medium supplemented with 500 ⁇ g/ml Carbenicillin, 200 ⁇ g/ml Augmentin and 50 ⁇ g/ml Kanamycin.
- Kan resistant transformant plants were obtained for both constructs, but no yellow silencing seedlings were obtained for construct pKIIGPS.
- PVX/GFP amplicon and C-24 plants were also transformed with constructs based on GFP homology as a trigger for spreading. Seeds from transformed PVX/GFP amplicon plants were germinated in GM plates under Kan selection and, after one week, small white (for PDS-carrying constructs) or yellow (for sulphur-carrying constructs) seedlings were visible. Nevertheless, these plants were not viable and died before producing the first true leaves. Seeds were then plated in GM medium without Kan selection and in the presence of sucrose. In addition, plates carrying the PDS constructs were put under dim light, to prevent excess of photobleaching. After 4 weeks in growth room there were many tiny white plants in the PDS plates and some yellow plants in the sulphur plates.
- virus-based constructs e.g. Amplicons
- an inducer a hairpin construct carrying an inverted repeat of a fragment of the transgene e.g. GFP gene.
- the “spreading constructs” can be the same as the GFP/PDS and GFP/sulphur ones used in Examples 6 and 7.
- Both hairpin and spreading constructs may be put under a DEX promoter inducible by dexametasone, as well as under the 35S promoter.
- pFGC5941 (ChromDB, Arizona), which confers resistance to BASTA and drives transcription from 35S promoter, so that expression will be constitutive.
- a 686 nt fragment of GFP was amplified using primers GFP-1(X/A) (5′ aattcccgggcgcgccATGAAAGGAGAAGAACTTT), where the sequence in upper case corresponds to GFP and the sequence in lower case includes sites for XmaI and AscI restriction enzymes, and primer GFP-4(X/S) (5′ atattctagatttaaaTTCCGTCCTCCTTGAAAT), where the sequence in upper case corresponds to GFP and the one in lower case includes sites for XbaI and SwaI restriction enzymes.
- the amplified fragment (GF) was digested with SwaI and AscI and introduced into pFGC5941 previously digested with the same enzymes, to produce pssGF1.
- the same PCR fragment was then digested with XbaI and XmaI and introduced into pssGF1 previously digested with the same enzymes, to produce pGF/FG, where the GFP fragments are in inverted orientation respect to each other and separated by an intron already present in the original pFGC5941 vector ( FIG. 10 ).
- pGF/FG was digested with XmaI, blunt ended with T4 DNA polymerase, and redigested with XhoI, releasing the hairpin (GF-intron-FG).
- the hairpin was then ligated into pTA 231 vector (kindly provided by Prof. N. H. Chua, Rockefeller Univ, New York, USA) previously digested with PacI, blunt-ended with T4 DNA polymerase and redigested with XhoI to produce pTAdsGF, where the GF hairpin is under the influence of a promoter inducible by dexametasone ( FIG. 11 ).
- the fragment GF-intron from pssGF1 was introduced into pTA231 in the same way, generating the construct pTAssGF, which should not produce any silencing.
- pTAssGF and pTAdsGF were transformed into C-24, GFP and GFP/sde1 mutant plants. Seeds from primary transformation of GFP plants were germinated and selected in the presence of BASTA. Of 20 lines, 14 were green, indicating that in these lines the inducible promoter remains inactive before induction. Appropriate hairpin inducible lines are selected as a basis for subsequent transformations with different spreading constructs and to create a high thoughput system, using a cDNA library cloned into a GFP gene, for transformation and silencing any gene in Arabidopsis.
- Binary vectors and Agrobacterium strains used for rice transformation are the following:
- pGF-FG LB-MASt::bar::MASp-CaMV35Sp::GF-ChsAintl::FG::OCSt-RB (based upon pFGC5941 vector system)
- pRT104, pRT105 and pRT106 were constructed by inserting PCR products into the ndeI site of the gfp gene of pGVT1 (made available by V. Thole, John Innes Centre, UK).
- pGVT1 LB-NOSp::nptII::NOSt-CaMV35Sp::gfp::St-RB (pGreen-based vector)
- pRT104 a 356 nt fragment of the osga gene was amplified by from rice wt genomic DNA (Nipponbare) and inserted in sense orientation into the ndeI site of the gfp gene of pGVT1.
- pRT105 a 356 nt fragment of the osga gene was amplified by from rice wt genomic DNA (Nipponbare) and inserted in antisense orientation into the ndeI site of the gfp gene of pGVT1.
- pRT106 a 639 nt fragment of the wx gene was amplified by from rice wt genomic DNA (Nipponbare) and inserted in sense orientation into the ndeI site of the gfp gene of pGVT1.
- Plasmids were transformed into E. coli strain DH5 using the PEG-transformation technique and into Agrobacterium strains LBA4404 and GM3101 using a freeze-thaw technique.
- Agrobacterium strain harboured the following plasmids
- Mature seeds of rice ( Oryza sativa L.) variety Nipponbare were used for callus production. Dehusked seeds were sterilised with half strength commercial bleach for 15 min and rinsed three times with sterile distilled water. The embryos were aseptically removed under a dissecting microscope and plated onto NBm medium (macro-element N6, micro-elements B5, Fe-EDTA, 30 g l ⁇ 1 sucrose, 2 mg l ⁇ 1 2,4-D, 300 mg l ⁇ 1 casein hydrolysate, 500 mg l ⁇ 1 L-glutamine, 500 mg l ⁇ 1 L-proline, 2.5 g l ⁇ 1 Phytagel, pH 5.8, filter-sterilized vitamins B5 added after autoclavage) for 3 weeks in the dark at 25° C.
- NBm medium macro-element N6, micro-elements B5, Fe-EDTA, 30 g l ⁇ 1 sucrose, 2 mg l ⁇ 1 2,4-D, 300 mg
- NBm medium ⁇ 100 globules per plate
- Agrobacterium strains were grown for 2 d at 28° C. on solid MG/L medium (Garfinkel and Nester 1980) supplemented by 200 M acetosyringone, 50 mg l ⁇ 1 Kanamycin (selection for pGreen- and pFGC5941-based vectors) and 10 mg l ⁇ 1 tetracyclin (selection for pSoup-based vectors).
- Bacteria cells were scooped up from the plate, re-suspended in 20 ml of SU4 liquid medium (macro-element N6, micro-elements MS, Fe-EDTA, 10 g l ⁇ 1 sucrose, 10 g l ⁇ 1 mannitol, pH 5.5, without antibiotics) and shaken for 1 hour at 28° C.
- co-cultivation medium NBm medium supplemented by 200 M acetosyringone
- ENUs were put onto selection medium (NBm medium containing 150 mg l ⁇ 1 timentin plus either 5 mg l ⁇ 1 phosphinotrycin (PPT, selection using bar gene) or 100 mg l ⁇ 1 Geneticin (selection using nptII gene) in the dark at 25° C. L-glutamine was removed from all culture media when PPT was included. After two weeks culture, each callus (grown from an individual ENU) was split into 2 to 5 pieces. Pieces of callus were cultured for 3 additional weeks onto fresh NBm-based selection medium. The resistant calli grown from individual ENU, after 2+3 weeks selection, were or kept separated according to the separation undertaken at 2 weeks.
- selection medium NBm medium containing 150 mg l ⁇ 1 timentin plus either 5 mg l ⁇ 1 phosphinotrycin (PPT, selection using bar gene) or 100 mg l ⁇ 1 Geneticin (selection using nptII gene) in the dark at 25° C. L
- Transformed plants were regenerated from resistant calli using culture media all supplemented with 50 mg l ⁇ 1 Timentin and containing either 5 mg l ⁇ 1 phosphinotrycin (PPT, selection using bar gene) or 100 mg l ⁇ 1 Geneticin (selection using nptII gene).
- the resistant calli were transferred to PRm pre-regeneration medium (NBm medium without 2,4-D but with 2 mg l ⁇ 1 BAP, 1 mg l ⁇ 1 NAA, 5 mg l ⁇ 1 ABA) for 9 days in the dark at 28° C.
- Transformed rice plants from the 1 st round of transformation containing the transgenes and expressing small GF RNAs (20-30 nt) were selected using PCR analysis and Northern blots respectively. Two types of transgenic plant lines were identified: High and low production of small RNAs.
- T 1 seeds were obtained by self-pollination of primary transformed rice (T 0 ) plants.
- Analysis of plants from the 2 nd round of transformation may be used to demonstrate a slender phenotype for osga silencing and no iodine staining of pollen and embryos for wx silencing.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Provided are methods of silencing a target gene in an organism, which methods comprises the steps of: (a) providing a recombinant DNA construct including an expression cassette comprising: (i) a promoter, operably linked to, (ii) a chimeric nucleotide sequence encoding all or part of the target gene and a transgene, (b) transforming the organism with said DNA construct such that the expression cassette is inserted into the genome, and (c) initiating post transcriptional gene silencing (PTGS) of said transgene in said organism, whereby initiation of PTGS of the transgene causes silencing of the target gene in the organism. The methods are based on a phenomenon termed “spreading” whereby PTGS of the transgene can be used to spread in trans to silence, for example, endogenous target genes in the same genetic background as the chimeric gene to give consistent, maintained, silencing thereof. Also provided are related materials (e.g. recombinant constructs) and uses and methods based on these.
Description
- The present invention relates generally to gene silencing methods and materials employing recombinant gene constructs.
- Being able to silence target genes in organisms such as plants is of great interest as a means of modifying the phenotype of those organisms.
- RNA silencing is a nucleotide sequence-specific process of RNA degradation in higher plants (post-transcriptional gene silencing, PTGS), animals (RNA interference, RNAi) and fungi (quelling) as well as in unicellular eukaryotic algae (Carthew, 2001; Matzke et al., 2001; Waterhouse et al., 2001). In higher plants a natural role of RNA silencing is to protect against viruses (Al-Kaff et al., 1998; Covey et al., 1997; Hamilton and Baulcombe, 1999; Ratcliff et al., 1997). A role in genome protection is also likely because there is enhanced transposon mobility in RNA silencing-defective mutants of C. reinhardtii, C. elegans and transposition is suppressed by RNA silencing in D. melagonaster (Jensen et al., 1999; Ketting and Plasterk, 2000; Wu-Scharf et al., 2000).
- Double-stranded RNA (dsRNA) is a potent activator of RNA silencing (Fire et al., 1998). Consequently RNA silencing is activated by viral RNAs that replicate via double-stranded intermediates and by transgenes with inverted repeat (IR) structures that could be transcribed into dsRNA (Chuang and Meyerowitz, 2000; Smith et al., 2000; Waterhouse et al., 2001). Single-copy transgenes without IR structures can also activate RNA silencing (Elmayan and Vaucheret, 1996). In these cases it is unlikely that dsRNA would be produced by direct transcription and it is thought that single-stranded RNAs (ssRNAs) are converted into dsRNAs by an RNA-dependent RNA polymerase (RdRP) (Lindbo et al., 1993). In support of this hypothesis, putative RdRPs encoded by the SDE1/SGS2, QDE1 and EGO1 loci are required for RNA silencing in A. thaliana, N. crassa and C. elegans, respectively (Cogoni and Macino, 2000; Dalmay et al., 2000b; Mourrain et al., 2000; Smardon et al., 2000).
- Biochemical analyses of RNA silencing in D. melagonaster have shown that an RNaseIII (DICER) cleaves the dsRNAs into 21-25 nucleotide RNAs short interfering RNAs (siRNAs) that associate with a second RNase in an ‘RNA-induced silencing complex’ (RISC) (Bernstein et al., 2001; Hammond et al., 2000). RISC cleaves target single-stranded RNAs at a site that is complementary to the (antisense) siRNA. Thus, the role of the siRNAs is to provide sequence-specificity to RNA silencing (Elbashir et al., 2001). Plant DICER and RISC have not yet been identified. However, siRNAs are present in plant RNA silencing systems suggesting that mechanisms are conserved across kingdoms (Hamilton and Baulcombe, 1999).
- In plants, viruses carrying portions of host genes can initiate silencing of the corresponding RNA through a process known as virus-induced gene silencing (VIGS) (Kumagai et al., 1995; Ruiz et al., 1998). In some instances, when the target sequence is from a transgene, the viral RNA is eventually eliminated by the silencing process. However, even in the absence of the virus, the transgene remains silenced. VIGS of transgenes is associated with sequence-specific methylation of transgene DNA (Jones et al., 1999). This process, termed RNA-directed DNA methylation (RdDM), is a consequence of dsRNA or siRNAs interacting directly with the target DNA (Wassenegger, 2000).
- To account for the transition from virus-dependence to virus-independence it has been proposed that there are different phases of the RNA silencing mechanism referred to as initiation and maintenance (Ruiz et al., 1998). Consistent with this idea it was shown in Arabidopsis that the two phases could be differentiated by mutation analysis and by the methylation of a GFP transgene. In wild-type plants there is both initiation and maintenance of GFP silencing and RdDM of the GFP transgene. In contrast in sde1/sgs2 and sde3 mutants there is initiation but not maintenance and the transgene is not methylated (Dalmay et al., 2001).
- However, a virus-free maintenance phase has only been observed when transgenes were targeted (Jones et al., 1999; Lindbo et al., 1993; Ruiz et al., 1998). VIGS of two different endogenous genes was not maintained in the absence of the virus, was not dependent on SDE1/SGS2 and SDE3 and did not lead to RdDM of the corresponding DNA (Dalmay et al., 2001; Jones et al., 1999; Ruiz et al., 1998; Thomas et al., 2001).
- Again considering transgenes, the transition from initiation to maintenance is also observed when RNA silencing of the transgenes is triggered by delivery of ectopic DNA via Agrobacterium infiltration, by bombardment or in grafting experiments (Palauqui and Balzergue, 1999; Palauqui et al., 1997; Voinnet and Baulcombe, 1997; Voinnet et al., 1998). In these systems, localized initiation of RNA silencing triggers systemic silencing throughout the plant. However, at least following Agrobacterium infiltration or bombardment, systemic silencing is maintained even if the region in which silencing is initiated is removed.
- Lipardi et al (2001) Cell Vol 107: 297-307 discuss a role for siRNAs as primers to transform mRNA into dsRNA.
- Sijen et al (2001) Cell Vol 107: 1-20 discuss a role for RNA amplification in dsRNA-triggered gene silencing.
- It is apparent from the forgoing that novel methods or materials for effectively silencing a target gene, such as an endogenous gene, within an organism, would represent a useful contribution to the art.
- The present inventors provide herein novel but powerful systems which have utility inter alia for silencing of endogenous genes. The inventors closely investigated the maintenance phase of RNA silencing and its association with spreading of both targeting and DNA methylation (as used herein, the term “spreading” is used to describe a molecular process rather than the systemic movement of a silencing signal). As a result of spreading all parts of a targeted transcript are targets of RNA silencing even if the dsRNA initiator sequence corresponds to only a fragment of it. The inventors have demonstrated inter alia that spreading and maintenance are closely associated, both seemingly being dependent on a putative RdRP. They have also demonstrated that spreading requires transcription of the target RNA. Combined these data support a model of RNA silencing in which spreading of targeting and maintenance involve production of dsRNA by an RdRP using the target sense RNA as a template.
- It was known that even when a systemic gene silencing initiator is from only a part of the target GFP sequence, the maintenance phase of RNA silencing is associated with methylation of the entire transcribed region of the transgene (Jones et al., 1999; Thomas et al., 2001). Similarly, in tissues exhibiting systemic silencing of GFP, all parts of the transgene transcript were targets of RNA silencing, irrespective of whether the initiator sequence was a 5′ or 3′ fragment of the transcribed sequence (Voinnet et al., 1998). In VIGS it was known that DNA methylation spreads beyond the initiator sequence (Jones et al., 1999).
- The inventors herein provide methods and materials utilising spreading in trans which in preferred embodiments may be used to provide consistent, maintained, silencing of endogenous genes, optionally in a conditional matter. No such spreading-based systems were disclosed in the prior art, and they have utility inter alia for functional genomics. For example the spreading-based system facilitates gene-function studies e.g. in A. thaliana.
- Results shown herein demonstrate that it is possible to use spreading as a technology for silencing endogenes e.g. using a viral amplicon as inducer of silencing of transgene-endogene chimeras. Spreading can take place either from only one direction (3′ to 5′) or in both directions. The length of the homologous sequences can be relatively short.
- Generally speaking the systems of the present invention for silencing target sequences are based on two elements (i) an initiator element which can serve to initiate gene silencing in an organism against an appropriate sequence, such as a transgene sequence, and (ii) a receptor element which includes an element which can be silenced by the initiator construct (e.g. a transgene which is identical to all or part of that initiator element) plus also a sequence identical to the intended target of silencing. The two receptor elements are present in the organism in the same genetic background e.g. introduced therein by transformation with a DNA construct.
- The elements may be provided by a “triggering construct” which provides the dsRNA to initiate or trigger RNA silencing, and a “spreading construct” which carries a chimeric gene composed of a portion of the triggering construct plus sequence from an endogenous cDNA. Such a construct provides the transgenic RNA where spreading can occur, leading ultimately to silencing of the endogenous gene in the organism.
- Thus in one aspect there is provided a method of silencing a target gene in an organism, which method comprises the steps of:
-
- (a) providing a DNA construct including an expression cassette comprising (i) a promoter, operably linked to (ii) a chimeric nucleotide sequence encoding all or part of the target gene and a transgene,
- (b) transforming the organism with said DNA construct such that the expression cassette is inserted into the genome, and
- (c) initiating PTGS of said transgene in said organism, whereby initiation of PTGS of the transgene causes silencing of the target gene in an organism.
- These steps (a)\(b) and (c) may be performed in any order i.e. the PTGS of the transgene may be initiated or extant in the organism prior to provision, introduction, or transformation of the chimeric nucleotide sequence.
- “Silencing” is a term generally used to refer to suppression of expression of a gene (generally by PTGS). The degree of reduction may be so as to totally abolish production of the encoded gene product, but may also be such that the abolition of expression is not complete, with some small degree of expression remaining. The term should not therefore be taken to require complete “silencing” of expression. It is used herein where convenient because those skilled in the art well understand this. In preferred embodiments the silencing will be maintained even if the initiator of the PTGS of the transgene is removed.
- “Gene” used broadly coding sequence in the DNA genome of an organism which is, or may be, expressed via transcription to mRNA and translation to a protein according to well established principles. It will generally be an endogenous gene of the organism. Preferred target genes are discussed below.
- The “transgene” is foreign (non-native) to the organism, which is to say that it does not occur naturally in the organism's genome.
- The “initiation” of silencing of the transgene may be by a variety of methods which are discussed in more detail hereinafter. Generally it may comprise the step of introducing into the organism a further nucleic acid construct which includes sequence corresponding to the transgene sequence such as to initiate PTGS of the transgene. As stated above, the (silenced) transgene may already be present in the organism prior to the introduction of chimeric sequence.
- Where the chimeric sequence is under the control of an inducible promoter, the method may further include the step of causing or permitting transcription from the promoter such as to produce an mRNA transcript of the expression cassette.
- Some embodiments and further aspects of the invention will now be described in more detail:
- DNA Construct
- Nucleic acid constructs according to the present invention will be recombinant and may be provided isolated and/or purified, in substantially pure or homogeneous form, or free or substantially free of other nucleic acid. The term “isolated” encompasses all these possibilities.
- Since nucleic acid may be double stranded, where nucleic acid (or nucleotide sequence) of the invention is referred to herein, use of the complement of that nucleic acid (or nucleotide sequence) will also be embraced by the invention. The ‘complement’ in each case is the same length as the reference, but is 100% complementary thereto whereby by each nucleotide is base paired to its counterpart i.e. G to C, and A to T or U.
- Generally speaking, in the light of the present disclosure, those skilled in the art will be able to construct vectors according to the present invention. Such vectors may include, in addition to the promoter, a suitable terminator or other regulatory sequence such as to define an expression cassette comprising the chimeric sequence.
- For further details see, for example, Molecular Cloning: a Laboratory Manual: 2nd edition, Sambrook et al, 1989, Cold Spring Harbor Laboratory Press. Many known techniques and protocols for manipulation of nucleic acid, for example in preparation of nucleic acid constructs, mutagenesis, sequencing, introduction of DNA into cells and gene expression, and analysis of proteins, are described in detail in Protocols in Molecular Biology, Second Edition, Ausubel et al. eds., John Wiley & Sons, 1992. Specific procedures and vectors previously used with wide success upon plants are described by Bevan, Nucl. Acids Res. (1984) 12, 8711-8721), and Guerineau and Mullineaux, (1993) Plant transformation and expression vectors. In: Plant Molecular Biology Labfax (Croy RRD ed) Oxford, BIOS Scientific Publishers, pp 121-148.
- Thus an additional optional feature of a construct used in accordance with the present invention is a transcriptional terminator. For example the transcriptional terminator from nopaline synthase (nos) gene of agrobacterium tumefaciens (Depicker, A., et al (1982), J. Mol. Appl. Genet., 1: 561-573) may be used. Other suitable transcriptional terminators will be well known to those skilled in the art.
- For embodiments which are practised in plants, the expression cassette will generally be situated between border sequences and are capable of being inserted into a plant genome under appropriate conditions. Generally this may be achieved by use of so called “agro-infiltration” which uses Agrobacterium-mediated transformation. Briefly, this technique is based on the property of Agrobacterium tumafaciens to transfer a portion of its DNA (“T-DNA”) into a host cell where it may become integrated into nuclear DNA. The T-DNA is defined by left and right border sequences which are around 25 nucleotides in length. In the present invention the border sequences are included around the transfer nucleotide sequence (the T-DNA) with the whole vector being introduced into the plant by agro-infiltration, optionally in the form of a binary-transformation vector. Thus the construct may include border sequences which permit the transfer of the transfer nucleotide sequence into a plant cell nucleus. Methods are described in more detail in the Examples hereinafter.
- Aspects of the present invention include the isolated recombinant DNA construct described above. Also provided is a composition comprising a plurality of said constructs, each including a separate target gene (preferably from the same organism). Also provided are kits comprising one or more said constructs, and their use in the methods described herein.
- Promoter
- By “promoter” is meant a sequence of nucleotides from which transcription may be initiated of DNA operably linked downstream (i.e. in the 3′ direction on the sense strand of double-stranded DNA). “Operably linked” means joined as part of the same nucleic acid molecule, suitably positioned and oriented for transcription to be initiated from the promoter. Nucleic acid operably linked to a promoter is “under transcriptional initiation regulation” of the promoter.
- In preferred embodiments the promoter may be inducible. The term “inducible” as applied to a promoter is well understood by those skilled in the art. In essence, expression under the control of an inducible promoter is “switched on” or increased in response to an applied stimulus. The nature of the stimulus varies between promoters. Some inducible promoters cause little or undetectable levels of expression (or no expression) in the absence of the appropriate stimulus. Other inducible promoters cause detectable constitutive expression in the absence of the stimulus. Whatever the level of expression is in the absence of the stimulus, expression from any inducible promoter is increased in the presence of the correct stimulus.
- In preferred embodiments, both “trigger” and “spreading” constructs are placed under individual inducible promoters such as to permit the triggering of silencing at different times and conditions.
- Suitable plant active promoters will be well known to those skilled in the art. Preferred promoters may include the 35S promoter of cauliflower mosaic virus or the nopaline synthase promoter of Agrobacterium tumefaciens (Sanders, P. R., et al (1987), Nucleic Acids Res., 15: 1543-1558). These promoters are expressed in many, if not all, cell types of many plants. If the target gene is to be silenced following a defined external stimulus the construct may incorporate a promoter that is be activated specifically by that stimulus. Promoters that are both tissue specific and inducible by specific stimuli may be used. Suitable promoters may include the maize glutathione-S-transferase isoform II (GST-II-27) gene promoter which is activated in response to application of exogenous safener (WO93/01294, ICI Ltd). Another suitable (preferred) promoter may be the DEX promoter (Plant Journal (1997) 11: 605-612).
- Chimeric Sequence
- The chimeric sequence will include all or part of the target gene and the transgene.
- In preferred embodiments the transgene is GFP or GUS, although (as shown in the examples) it could even be a viral fragment or an exogenous sequence inserted into the viral genome, such as GFP in PVX/GFP amplicon.
- The part of the target gene will include more than just the promoter of the target gene, and will preferably include at least the initiating ATG codon of the target gene. It may optionally include all or part of the terminator.
- The sequences need not run intact contiguously. For example the target gene may be inserted within the transgene, as in the Examples below. Provided they are ultimately present in the same genetic background, they need not form part of a single ORF.
- It should be stressed that the complete sequence corresponding to the gene coding sequence (the “targeting” sequence) need not be used. For example fragments of sufficient length may be used. It is a routine matter for the person skilled in the art to screen fragments of various sizes and from various parts of the coding sequence to optimise the relationship between target and targeting sequence. Likewise it may be preferable that there is complete sequence identity between the targeting sequence in the vector and the target sequence in the plant, although total similarity of sequence is not essential. One or more nucleotides may differ in the targeting sequence from the target gene. Thus, a targeting sequence employed in a construct in accordance with the present invention may be a wild-type sequence (e.g. gene) selected from those available, or a substantially homologous mutant, derivative, variant or allele, by way of insertion, addition, deletion or substitution of one or more nucleotides, of such a sequence. A typical construct may include a sequence wherein the targeting sequence and the sequence within the target gene are substantially homologous, by which is meant that the sequence in question shares at least about 70%, or 80% identity, most preferably at least about 90%, 95%, 96%, 97%, 98% or 99% identity with the reference sequence. The sequence will preferably be at least 21, 22, 23, 24, or 25 nucleotides in length. It may be longer e.g. at least 200 nt or 745 nt.
- Identity may be at the nucleotide sequence and/or encoded amino acid sequence level. Homology may be over the full-length of the relevant sequence shown herein (e.g. in the sequence Annex) or may be over a part of it. Identity may be determined by the TBLASTN program, of Altschul et al. (1990) J. Mol. Biol. 215: 403-10, or BestFit, which is part of the Wisconsin Package,
Version 8, September 1994, (Genetics Computer Group, 575 Science Drive, Madison, Wis., USA, Wisconsin 53711). Preferably sequence comparisons are made using FASTA and FASTP (see Pearson & Lipman, 1988. Methods in Enzymology 183: 63-98). Parameters are preferably set, using the default matrix, as follows: Gapopen (penalty for the first residue in a gap): −12 for proteins/−16 for DNA; Gapext (penalty for additional residues in a gap): −2 for proteins/−4 for DNA; KTUP word length: 2 for proteins/6 for DNA. - In addition to the target gene relationship, all these comments apply mutatis mutandis to the transgene in the chimeric (spreading) construct and its counterpart on the initiator (triggering) construct, where appropriate.
- Choice of Target Sequence
- Preferred target genes may include those which confer ‘unwanted’ traits in the plant and which it may therefore be desired to silence. Examples include ripening specific genes in tomato to improve processing and handling characteristics of the harvested fruit; genes involved in pollen formation so that breeders can reproducibly generate male sterile plants for the production of F1 hybrids; genes involved in lignin biosynthesis to improve the quality of paper pulp made from vegetative tissue of the plant; gene silencing of genes involved in flower pigment production to produce novel flower colours; gene silencing of genes involved in regulatory pathways controlling development or environmental responses to produce plants with novel growth habit or (for example) disease resistance; elimination of toxic secondary metabolites by gene silencing of genes required for toxin production.
- A further possibility is to target a conserved sequence of a gene, e.g. a sequence that is characteristic of one or more genes in one or more pathogens against which resistance is desired, such as a regulatory sequence. Thus a construct may target a conserved sequence within a target gene group such as to down-regulate expression of one or more members of a target gene group. More than one targeting sequence may be included.
- Choice of Transgene Silencing Method
- The initial silencing step may be achieved by any conventional method appropriate to the organism in question. This then spreads in trans to the target gene.
- For instance in plants it could be by silencing of the transgene by any of:
-
- (i) VIGS—as discussed in relation to background art, viruses carrying portions of host genes (in this case transgenes) can initiate silencing of the corresponding RNA (Kumagai et al., 1995; Ruiz et al., 1998) which remains silenced even in the absence of the virus (Jones et al., 1999).
- Thus in these embodiments of the present invention, initiation of PTGS of said transgene in the organism may be achieved by introducing a virus (or sequence derived therefrom) including all or part of the transgene sequence.
- Preferred VIGS vectors include those based on PVX, TRV, TMV and geminiviruses (Kumagai et al., 1995; Kjemtrup et al., 1998; Ruiz et al., 1998; Peele et al., 2001; Ratcliff et al., 2001)
-
- (ii) Transgene hairpin—Silencing, including silencing of endogenous genes, can be initiated by methods well known to those skilled in the art e.g. analogous to those described in Chuang and Meyerowitz, 2000; Smith et al., 2000; or Wesley et al., 2001. The use of such Inverted Repeats (IR) may be preferable where it is desired not to introduce replicating virus-derived material into the organism. The use of IR-based spreading systems as described herein is particularly useful for high-throughput genomic analysis.
- (iii) Transgene Silencing—PTGS induced by transgenes, even in single copy, is discussed by H. Vaucheret, et al., Plant J. 16, 651-659 (1998). This is preferably provided by use of plants or lines in which ‘resident’ PTGS against transgene is already extant, and into which the chimeric DNA construct may be introduced.
- In a further embodiment there is provided a method of silencing a target gene in an organism, which method comprises the steps of:
-
- (a) providing the organism which has been transformed with a transgene which has been silenced with PTGS,
- (b) transforming said organism with a DNA construct including an expression cassette comprising (i) a promoter, operably linked to (ii) a chimeric nucleotide sequence encoding all are part of the target gene and a transgene,
- (iv) Systemically induced transgene silencing—in some examples of PTGS, silencing is initiated in a localised region of the plant. A signal molecule is produced at the site of initiation and mediates systemic spread of silencing to other tissues of the plant (O. Voinnet and, D. C. Baulcombe, Nature 389, 553 (1997); J.-C. Palauqui, and S. Balzergue, Curr. Biol. 9, 59 (1999))
- (v) Cytoplasmically replicating constructs—silencing constructs are disclosed e.g. in WO95/34668 (Biosource). Preferred systems are those based on so-called ‘amplicons’—see Angell & Baulcombe (1997) The EMBO Journal 16, 12:3675-3684 or WO98/36083 of Plant Bioscience Limited. ‘Amplicons’, as described in WO98/36083, comprise a promoter operably linked to a viral replicase, or a promoter sequence operably linked to DNA for transcription in a plant cell of an RNA molecule that includes plant virus sequences (i.e. cis elements such as one or more sub-genomic promoters, and trans elements such as a replicase) that confer on the RNA molecule the ability to replicate in the cytoplasm of a plant cell following transcription. The transcripts replicate as if they are viral RNAs, and comprise a targeting sequence corresponding to the gene of interest (‘the target gene’). Other sequence from the viral RNA may be omitted to give a minimal amplicon. It should be stressed that the amplicon targeting gene is directed towards the transgene i.e. a transgene-targeting sequence. They may be introduced as stable transgenes into the genome of the same plant by transformation and/or crossing. Alternatively they may be introduced by agroinfiltration for transient expression.
- Thus in one embodiment the invention provides a method of silencing a target gene in an organism, which method comprises the steps of:
-
- (a) providing a first DNA construct including an expression cassette comprising (i) a promoter, operably linked to (ii) a chimeric nucleotide sequence encoding all are part of the target gene and a transgene,
- (b) providing a second DNA construct including an expression cassette comprising (i) a promoter, operably linked to (ii) DNA for transcription in a plant cell of an RNA molecule that includes (I) plant virus sequences that confer on the RNA molecule the ability to replicate in the cytoplasm of a plant cell following transcription (II) a targeting sequence corresponding to the transgene,
- (c) transforming the organism with said DNA constructs such that the expression cassettes are inserted into the genome, and optionally (e.g. where the promoter of either construct is inducible)
- (d) causing or permitting transcription of the expression cassettes such as to cause silencing of the target gene in an organism.
Plants and Methods of Transformation
- In preferred embodiments the invention is performed (i.e. the DNA construct is used) in order to silence a target endogenous gene in a plant which is transformed with said construct. The invention is applicable to both monocot and dicot plants.
- Thus in one aspect there is provided a method of silencing a target gene in an organism, which method comprises the steps of:
-
- (a) providing the organism transformed with a DNA construct including an expression cassette comprising (i) a promoter, operably linked to (ii) a chimeric nucleotide sequence encoding all are part of the target gene and a transgene, and where appropriate causing or permitting transcription of the chimeric sequence,
- (b) initiating PTGS of said transgene in the organism using any of the methods described herein such as to cause silencing of the target gene in the organism.
- The present invention may be used in plants such as crop plants, including cereals and pulses, maize, wheat, potatoes, tapioca, rice, sorgum, millet, cassaya, barley, pea and other root, tuber or seed crops. Important seed crops are oil seed rape, sugar beet, maize, sunflower, soybean and sorghum. Horticultural plants to which the present invention may be applied may include lettuce, endive and vegetable brassicas including cabbage, broccoli and cauliflower, and carnations and geraniums. The present invention may be applied to tobacco, cucurbits, carrot, strawberry, sunflower, tomato, pepper, chrysanthemum, poplar, eucalyptus and pine.
- For genomic analysis (see below), it may be preferred to use Nicotiana benthamiana, Arabidopsis thaliana or Oryza sativa.
- Any appropriate method of plant transformation may be used to generate plant cells containing a construct within the genome in accordance with the present invention. Following transformation, plants may be regenerated from transformed plant cells and tissue. Successfully transformed cells and/or plants, i.e. with the construct incorporated into their genome, may be selected following introduction of the nucleic acid into plant cells, optionally followed by regeneration into a plant, e.g. using one or more marker genes such as antibiotic resistance.
- All the following methods may also be used analogously to further (or earlier) transform plants with the transgene-silencing constructs (e.g. amplicon) in embodiments in which they are used.
- Plants transformed with the DNA construct may be produced by standard techniques which are already known for the genetic manipulation of plants. DNA can be transformed into plant cells using any suitable technology, such as a disarmed Ti-plasmid vector carried by Agrobacterium exploiting its natural gene transfer ability (EP-A-270355, EP-A-0116718, NAR 12(22) 8711-87215 1984), particle or microprojectile bombardment (U.S. Pat. No. 5,100,792, EP-A-444882, EP-A-434616) microinjection (WO 92/09696, WO 94/00583, EP 331083, EP 175966, Green et al. (1987) Plant Tissue and Cell Culture, Academic Press), electroporation (EP 290395, WO 8706614 Gelvin Debeyser—see attached) other forms of direct DNA uptake (DE 4005152, WO 9012096, U.S. Pat. No. 4,684,611), liposome mediated DNA uptake (e.g. Freeman et al. Plant Cell Physiol. 29: 1353 (1984)), or the vortexing method (e.g. Kindle, PNAS U.S.A. 87: 1228 (1990d). Physical methods for the transformation of plant cells are reviewed in Oard, 1991, Biotech. Adv. 9: 1-11.
- Agrobacterium transformation is widely used by those skilled in the art to transform dicotyledonous species. Production of stable, fertile monocot transgenic plants may be achieved e.g. using the techniques of, or analogous to, Toriyama, et al. (1988) Bio/Technology 6, 1072-1074; Zhang, et al. (1988) Plant Cell Rep. 7, 379-384; Zhang, et al. (1988) Theor Appl Genet 76, 835-840; Shimamoto, et al. (1989) Nature 338, 274-276; Datta, et al. (1990) Bio/Technology 8, 736-740; Christou, et al. (1991) Bio/Technology 9, 957-962; Peng, et al. (1991) International Rice Research Institute, Manila, Philippines 563-574; Cao, et al. (1992) Plant Cell Rep. 11, 585-591; Li, et al. (1993) Plant Cell Rep. 12, 250-255; Rathore, et al. (1993) Plant Molecular Biology 21, 871-884; Fromm, et al. (1990) Bio/Technology 8, 833-839; Gordon-Kamm, et al. Plant Cell 2, 603-618; D'Halluin, et al. (1992) Plant Cell 4, 1495-1505; Walters, et al. (1992) Plant Molecular Biology 18, 189-200; Koziel, et al. (1993) Biotechnology 11, 194-200; Vasil, I. K. (1994) Plant Molecular Biology 25, 925-937; Weeks, et al. (1993) Plant Physiology 102, 1077-1084; Somers, et al. (1992) Bio/Technology 10, 1589-1594; WO92/14828). In particular, Agrobacterium mediated transformation is now emerging also as an highly efficient transformation method in monocots (Hiei et al. (1994) The Plant Journal 6, 271-282).
- The generation of fertile transgenic plants has been achieved in the cereals rice, maize, wheat, oat, and barley (reviewed in Shimamoto, K. (1994) Current Opinion in
Biotechnology 5, 158-162.; Vasil, et al. (1992) Bio/Technology 10, 667-674; Vain et al., 1995, Biotechnology Advances 13 (4): 653-671; Vasil, 1996, Nature Biotechnology 14 page 702). - Microprojectile bombardment, electroporation and direct DNA uptake are preferred where Agrobacterium is inefficient or ineffective. Alternatively, a combination of different techniques may be employed to enhance the efficiency of the transformation process, eg bombardment with Agrobacterium coated microparticles (EP-A-486234) or microprojectile bombardment to induce wounding followed by co-cultivation with Agrobacterium (EP-A-486233).
- Following transformation, a plant may be regenerated, e.g. from single cells, callus tissue or leaf discs, as is standard in the art. Almost any plant can be entirely regenerated from cells, tissues and organs of the plant. Available techniques are reviewd in Vasil et al., Cell Culture and Somatic Cel Genetics of Plants, Vol I, II and III, Laboratory Procedures and Their Applications, Academic Press, 1984, and Weissbach and Weissbach, Methods for Plant Molecular Biology, Academic Press, 1989.
- The particular choice of a transformation technology will be determined by its efficiency to transform certain plant species as well as the experience and preference of the person practising the invention with a particular methodology of choice. It will be apparent to the skilled person that the particular choice of a transformation system to introduce nucleic acid into plant cells is not essential to or a limitation of the invention, nor is the choice of technique for plant regeneration.
- In a further aspect of the present invention there is disclosed a host cell including, or transformed by, the DNA construct according to the present invention. Use of the construct as described above in the transformation (stable or transient) of a plant is also embraced by the invention. The host cell will preferably have incorporated into its genome a construct as described above (i.e. be transformed by it). Also according to the invention there is provided a plant cell having incorporated into its genome a DNA construct as disclosed. A further aspect of the present invention provides a method of making such a plant cell involving introduction of a vector including the construct into a plant cell. Such introduction should be followed by recombination between the vector and the plant cell genome to introduce the sequence of nucleotides into the genome. RNA encoded by the introduced nucleic acid construct may then be transcribed in the cell and descendants thereof, including cells in plants regenerated from transformed material. A gene stably incorporated into the genome of a plant is passed from generation to generation to descendants of the plant, so such descendants should show the desired phenotype.
- The present invention also provides a plant comprising a plant cell as disclosed. In addition to a plant, the present invention provides any clone of such a plant, seed, selfed or hybrid progeny and descendants, and any part of any of these, such as cuttings, seed.
- Methods of Identifying Gene Function
- A further aspect of the present invention provides a method of reducing or suppressing or lowering the level of a target gene in a plant cell, the method including causing or allowing transcription from the construct as disclosed above.
- In preferred forms the present invention is concerned with providing silencing-based methods are useful in functional genomics. Thus in one aspect of the present invention, the target gene may be of unknown phenotype, in which case the system may be employed to analyse the phenotype by generating a widespread null (or nearly null) phenotype. The target gene may be essential, which is to say that the null phenotype is lethal to the cell or tissue in question.
- In preferred embodiments, plants are first transformed with a single type of “triggering construct” (e.g. based on an inducible promoter and Amplicon or IR as described above). After that point only simple high throughput cloning steps are needed. A cDNA (or other) library can be cloned into a corresponding “spreading construct”. This library is then used for large scale plant transformations in order to generate an extensive collection of transformant plants. Following induction of the triggering construct, and due to the dominant character of RNA silencing, these plants can be immediately screened for specific null-phenotypes. The silenced gene sequences of interest in the phenotypes can be PCR-amplified easily by using primers specific to the spreading construct (and in particular the portion therein in which the library insert is introduced). This system provides an excellent inducible and dominant null-phenotype generating machine for high throughput forward genetic studies in A. thaliana.
- Furthermore, due to the dsRNA synthesis during the spreading phenomenon, the antisense siRNAs needed to target endogenous mRNA will be produced independently of the orientation of the endogenous cDNA in the spreading construct. This further facilitates the cloning steps.
- This aspect of the invention may comprise a method of characterizing a target gene comprising the steps of:
-
- (a) silencing the target gene in a part or at a certain development stage of the plant using the system described above,
- (b) observing the phenotype of the part of the plant in which, or when, the target gene has been silenced.
- Thus in one embodiment the invention provides a method of characterizing a target gene comprising the steps of:
-
- (a) providing a first DNA construct (“spreading constuct”) including an expression cassette comprising (i) a promoter, operably linked to (ii) a chimeric nucleotide sequence encoding all are part of the target gene and a transgene,
- (b) providing a plant transformed with a second DNA construct (“triggering construct”) capable of triggering silencing of the transgene,
- (c) transforming the organism with said second DNA construct such that the expression cassette is inserted into the genome,
- (d) causing or permitting transcription of the expression cassettes such as to cause silencing of the target gene in an organism.
- (e) observing the phenotype of the plant in which the target gene has been silenced.
- In preferred embodiments the silencing is initiated using an inducible promoter e.g. applying an exogenous inducer to cause transcription of the triggering construct at an appropriate time. The phenotype is then observed.
- Generally the observation will be contrasted with a plant wherein the target gene is being expressed in order to characterise (i.e. establish one or more phenotypic characteristics of) the gene.
- In a further aspect there is disclosed a method of altering the phenotype of a plant comprising use of the silencing method discussed above. Traits for which it may be desirable to change the phenotype include the following: colour; disease or pest resistance; ripening potential; male sterility etc.
- Detecting Target Silencing
- In addition to monitoring phenotype, the methods of the present invention may be followed by assessing the silencing of the target gene.
- Detection may be using any method known in the art or described herein. Detection may be by analysis of siRNAs and may involve the steps of:
-
- (i) obtaining sample material from the organism,
- (ii) extracting nucleic acid material therefrom,
- (iii) analysing the extracted nucleic acid in order to detect the presence or absence of siRNAs therein corresponding to the target gene. The result of the analysis in step (iii) may be correlated with the presence of silencing in the organism.
- The ‘sample’ may be all or part of the organism, but will include at least some cellular material.
- Alternatively it may be preferred to investigate methylation of the target sequence.
- The invention will now be further described with reference to the following non-limiting Figures and Examples. Other embodiments of the invention will occur to those skilled in the art in the light of these.
-
FIG. 1 . Spreading of targeting on a GFP transgene. - (A) Schematic representation of the experimental procedure. Post-transcriptional gene silencing (PTGS) of a 35S:GFP:NOS transgene in N. benthamiana plants (line 16c) was triggered by inoculating with TRV carrying a region of the GFP sequence. Subsequently plants were challenge-inoculated with PVX carrying another region of the GFP transgene and resistance was assessed. Plants infected with TRV:00 or TRV:35S were used as non-PTGS controls. (B) TRV:00-, TRV:35S-, TRV:GF-, TRV:P- and TRV:NOS-infected 16c plants photographed at 21 dpi under ultra violet light. Silencing of GFP is evident as red fluorescence which is due to the chlorophyll. Infection with TRV:35S induces transcriptional gene silencing (TGS) of the transgene. (C) PVX RNA levels in TRV-infected plants challenge-inoculated with PVX:P. RNA samples were extracted from upper leaves of PVX:P-challenged plants at 10 dpi and a probe specific for PVX was used in Northern blot analysis. At this time point TRV:00-infected plants were not yet showing GFP silencing by PVX:P. Ethidium bromide (EtBr) stained rRNAs are shown in the lower panel. (D) Analysis of siRNAs (21/25 nucleotide in length) from TRV-inoculated plants at 21 dpi. Sense RNA probes were specific for antisense RNAs corresponding to the P region of GFP (top panel) or TRV (bottom panel).
-
FIG. 2 . Spreading of targeting on a GFP/PDS chimeric gene. - (A) Schematic representation of the GFP/PDS chimeric transgene including the 35S promoter, the GFP sequences and the PDS region. (B) GFP/PDS chimeric plants (line #D) inoculated with TRV:00, or TRV:GF photographed at 21 dpi. (C) Analysis of siRNAs (21/25 nucleotide in length) from TRV:GF- or TRV:PD-infected at 21 dpi. Sense RNA probes were specific for antisense RNAs corresponding to the GF region of GFP (top panel) or PD of the PDS (bottom panel).
-
FIG. 3 . Spreading requires transgene transcription. - (A) Schematic representation of the experimental procedure. Transcriptional gene silencing (TGS) of a 35S:GFP:NOS transgene in N. benthamiana (line 16c) was triggered by TRV:35S-infection. Following the onset of TGS, plants were inoculated with PVX carrying a region of the GFP transgene and siRNAs and DNA methylation corresponding to the rest of the GFP sequence were assessed. Plants infected with TRV:00 were used as a non-TGS control. (B) Analysis of siRNAs (21/25 nucleotide in length) from non-TGS (TRV:00) or TGS (TRV:35S) plants infected with PVX:GF or PVX:P. RNA samples were extracted from upper leaves at 21 days post-PVX infection. At this time point TRV:00-infected control plants were showing full GFP silencing by PVX:GF or PVX:P. Sense RNA probes were specific for antisense RNAs corresponding to the GF or P regions of GFP (top and bottom panel respectively). (C and D) Analysis of DNA methylation within GF and P regions by Sau96I digestion followed by quantitative PCR. DNA samples were prepared from non-TGS (TRV:00) (C) or TGS (TRV:35S) (D) plants infected with PVX:00, PVX:GF or PVX:P at 21 dpi. Amplification values represent the degree of DNA methylation. Values are the average of three independent experiments. The values represent the DNA methylation level: the higher the amplification value, the greater the degree of DNA methylation in the PCR template.
-
FIG. 4 . Spreading requires SDE1SGS2. - (A) Detection of GFP and TRV:GF RNAs in mock- or TRV:GF-inoculated wild-type (wt) or sde1/sgs2 mutant (sde1) 35S:GFP:NOS A. thaliana plants (top panel). RNA preparations were made from pools of 10 plants at 7-10 dpi and the probe used was specific to the GF region of the GFP RNA. Ethidium bromide (EtBr) stained rRNAs are shown in the lower panel. (B) Analysis of siRNAs (21/25 nucleotide in length) in wild-type (wt) and sde1/sgs2 TRV:GF-inoculated plants at 7-10 dpi. Sense RNA probes were specific for antisense RNAs corresponding to the GF or P regions of GFP (low and top panel respectively). (C) Schematic map of the 35S:GFP:NOS transgene in A. thaliana. Expected sizes (in kb) for total and relevant partial Sau96I restriction enzyme digestions and the P probe used for Southern analysis are indicated. (D) Southern blot analysis of Sau96I digested DNA extracted from pooled plants as described in (A). Sizes of relevant DNA fragments are indicated. Bands marked with an asterisk are due to a low level of methylation at the Sau96I site within the 35S promoter.
-
FIG. 5 . Spreading and endogenes. - (A) N. benthamiana non-transgenic plants inoculated with TRV:00, TRV:PD or TRV:S photographed at 21 dpi. (B) PVX RNA levels in TRV:00-, TRV:PD- or TRV:S-infected plants challenge-inoculated with PVX:PD or PVX:S. RNA samples were extracted from PVX-inoculated leaves at 4 dpi and a probe specific for PVX was used in Northern blot analysis. Ethidium bromide (EtBr) stained rRNAs are shown in the lower panel. (C) Analysis of siRNAs (21/25 nucleotide in length) from TRV:PD-, TRV:S-, TRV:RU- or TRV:BISCO-inoculated plants at 21 dpi. Sense RNA probes were specific for antisense RNAs corresponding to the PD, S, RU and BISCO regions of the PDS and rubisco genes.
-
FIG. 6 . This shows Table 1 listing the sequences of the oligonucleotides used in the Examples. -
FIG. 7 . Construction of pGIIGPS. L: left border of T DNA. R: right border. 35S P: 35S promoter. 35S T: 35 S terminator. IVS: intron from ST-LS1 gene from potato cloned in GUS. Showed as a black box. -
FIG. 8 . Construction of negative control pGIIGS. Abbreviations as inFIG. 7 . -
FIG. 9 . Construction of pKIIGPS. Abbreviations as inFIG. 7 . -
FIG. 10 . Construction of pGF/FG. ChsA: intron from Chalcone Sintase gene. OCS:octopine synthase 3′ polyadenylation sequence. Xh: XhoI. N: NcoI. As: AscI. Sw: SwaI. B: BamHI. A: AvrII. Xb: XbaI. P: PacI. Xm: XmaI. -
FIG. 11 . Construction of pTAdsGF. Ind Pro: stands for the elements of the inducible promoter. 3AT: Pea Rubisco small subunit gene terminator. -
- 1 Sequence of pKIIGPS.
- 2 Sequence of pKIIGS. 35S cassette with GUS and sulphur inserts.
- 3 Sequence of pGF/FG. Showed from promoter to terminator.
- 4 Inducible promoter and hairpin GF construct in pTAdsGF
- Experimental Procedures
- Use of genetically modified plant viruses was licensed by MAFF license PHL 24B/3654 (3/2001).
- Transgenic Plants
- The N. benthamiana 16c line and the A. thaliana GFP wild-type and sde1/sgs2 lines (wt[G] and sde1(GI) were described previously (Dalmay et al., 2000a; Dalmay et al., 2001; Ruiz et al., 1998). Visual observation of GFP fluorescence was performed according to Voinnet et al. (1998). The line #D was made as follows: a 600 bp GFP DNA fragment was PCR amplified using oligos GFP1 and GFP6 (see Table 1 for sequences) and cloned into the SmaI-digested pJIT60 vector (www.pgreen.ac.uk). Then, the KpnI/XhoI fragment was inserted into KpnI/XbaI-digested pGreen0229 binary vector (www.pgreen.ac.uk). A 416 bp N. benthamiana PDS cDNA fragment was PCR amplified using oligos PDS-5-AS and PDS-3-AS (see Table 1 for sequences) and cloned in the antisense orientation into the Bst1107I site of GFP. The resulting vector was used to obtain transgenic N. benthamiana according to Horsch et al. (Horsch et al., 1985).
- Viral Vectors and Virus Inoculations
- The primers used to PCR amplify the different regions of the GFP:NOS, PDS and rubisco genes (and the sizes of the PCR products) are as follows: GFP1 and GFP4 for GF (400 bp), GFP5 and GFP8 for P (332 bp), TNOS1 and TNOS3 for NOS (154 bp), PDS-5-AS and PDS-MID3 for PD (213 bp), PDS-MID5 and PDS-3-AS for S (216 bp), Rub-5-AS and Rud-MID3 for RU (272 bp) and Rub-MID5 and Rub-3-AS for BISCO (250 bp) (see Table 1 for sequences). These fragments were cloned into pGEM-Teasy (Promega), excised with SalI/ApaI and inserted into SalI/ApaI-digested pTV.00 (Ratcliff et al., 2001) to produce pTRV:GF, pTRV:P, pTRV:NOS, PTRV:PD, pTRV:S, pTRV:RU and PTRV:BISCO, respectively. The TRV:35S vector was described previously (Jones et al., 2001). TRV inoculations of N. benthamiana have been described previously (Ratcliff et al., 2001). For A. thaliana TRV:GF inoculations, 7 day old seedlings were vacuum-infiltrated with a pTRV:GF/pBINTRA6 Agrobacterium suspension mix (Ratcliff et al., 2001). pPVX:PD and pPVX:S vectors were obtained by cloning the PD and S fragments into the SmaI site of pGR107 (Jones at al., 1999). PVX:GF and PVX:P vectors were described previously (Ruiz et al., 1998; Voinnet et al., 1998). PVX inoculations of N. benthamiana were as described in Ruiz et al. (1998), Voinnet et al. (1998) and Jones et al. (1999).
- Nucleic Acid Analysis
- RNA was extracted using Tri-reagent (Sigma) according to the manufacturer's instructions. Total RNA was used for both high molecular weight RNA and siRNA analysis. Northern blot analysis were performed as described previously (Jones et al., 1998); siRNA analyses were performed as described in Hamilton & Baulcombe (1999). For siRNAs detection, probes were made by in vitro transcription from pKS (Stratagene) carrying the corresponding fragments cloned into the SmaI site. The TRV probe corresponds to a fragment of the TRV coat protein obtained by EcoRI digestion of pTV.00 (Ratcliff et al., 2001) and cloned into pKS. Genomic DNA was extracted using the DNeasy plant DNA extraction kit (Qiagen) according to the manufacturer's instructions. DNA gel-blot was performed as described previously (Jones et al., 1998). The DNA methylation analysis by Sau96I digestion and Taqman quantitative PCR was performed as described previously (Jones et al., 2001) using DNA prepared from upper leaves. The two oligos and the probe used for the analysis of the GF region were GF-5, GF-3, and GF-probe respectively (see Table 1 for sequences). The oligos and probes used for analysis of the P region and controls were described previously (Jones et al., 2001).
- The distribution of RNA silencing targets in VIGS had not previously been investigated.
- Therefore we carried out VIGS of a 35S:GFP:NOS transgene in N. benthamiana (line 16c) (Ruiz et al., 1998) using tobacco rattle virus (TRV) vectors carrying inserts corresponding to different parts of the transgene. We then monitored the RNA target of VIGS by challenge-inoculating plants with potato virus X (PVX) vectors carrying other parts of the GFP transgene (
FIG. 1A ) and by characterizing the siRNAs associated with silencing of the GFP mRNA. From our previous experiments we anticipated that the PVX RNA would not accumulate if it carries an insert that is target of RNA silencing. Accordingly, there would be accumulation of siRNAs corresponding to the target region of RNA silencing. - The initiator constructs in these experiments were TRV vectors carrying the 5′ or 3′ halves of the GFP coding region or the 3′ untranslated region (TRV:GF, TRV:P and TRV:NOS, respectively). As controls, plants were infected with TRV without an insert (TRV:00) or carrying the 35S promoter (TRV:35S). TRV:00 would not cause silencing of the transgene whereas TRV:35S would trigger transcriptional silencing of 35S-driven transgenes (Jones et al., 1999; Jones et al., 2001).
- By 21 days post inoculation (dpi) there was loss of green fluorescence, indicative of RNA silencing, in plants infected with TRV:35S, TRV:GF, TRV:P and TRV:NOS whereas plants infected with TRV:00 remained fully green fluorescent (
FIG. 1B ). Correspondingly, there was less GFP mRNA in silenced plants than in non-silenced plants (data not shown). These TRV-infected plants (21 dpi) were then challenge-inoculated with PVX:P (a PVX vector modified to carry the same 3′ part of the GFP sequence that is present in TRV:P) and levels of PVX viral RNA were assessed 10 days later.FIG. 1C shows that PVX:P accumulated at high levels in TRV:00 and TRV:35S infected plants and at low levels in TRV:GF, TRV:P or TRV:NOS infected plants. Thus the ‘P’ region of GFP was a target irrespective of whether the initiator was GF, P or NOS. - To characterize siRNAs we used a sense probe specific for the antisense 3′ part of GFP (P probe) and we sampled the TRV-infected tissues at 21 dpi. As shown in
FIG. 1D (top panel), antisense P-specific siRNAs (P-siRNAs) were present in samples from TRV:GF-, TRV:P- and TRV:NOS-infected plants but not in TRV:00- and in TRV:35S-infected plants. Similarly, GF-siRNAs and NOS-siRNAs were present in samples from TRV:GF-, TRV:P- and TRV:NOS-infected plants but not in those from TRV:00- and in TRV:35S-infected plants (data not shown). Thus, irrespective of whether the initiator sequence was GF, P or NOS, the siRNA population was distributed throughout the transcribed region of the GFP transgene. TRV-siRNAs were detected in all the TRV-infected plants (FIG. 1D , bottom panel) as expected from the finding that RNA silencing is a natural mechanism for virus resistance in plants (Hamilton and Baulcombe, 1999; Ratcliff et al., 1999). - These combined results demonstrate that the target of RNA silencing can spread within the transcribed regions of the transgene from the initiator region in both 3′ (from GF to P) and 5′ (from NOS to P) directions. Moreover, because NOS-siRNAs were produced following initiation with GF and vice versa, we have shown that spreading can extend further than the 332 bp corresponding to the P region. The presence of antisense siRNAs corresponding to sequences beyond the initiator region indicates that a dsRNA copy of the target has been produced. The absence of siRNAs corresponding to the coding region of the transgene in TRV:35S-infected plants correlates with our previous finding that 35S DNA methylation in TRV:35S-infected plants does not spread into the transcribed regions (Jones et al., 1999).
- We also investigated spreading of targeting in N. benthamiana carrying a chimeric GFP/PDS gene (line #D). This chimeric gene is composed of the 35S promoter driving transcription of a GFP sequence with an insertion of 429 bp of the N. benthamiana phytoene desaturase (PDS) cDNA (
FIG. 2A ). Inhibition of PDS causes suppression of carotenoid biosynthesis and susceptibility to photobleaching (Demmig-Adams and Adams, 1992; Kumagai et al., 1995; Ruiz et al., 1998). - It was believed that siRNAs corresponding to the PDS region of the chimeric gene (PDS-siRNAs) may be produced by spreading of targeting from a GFP initiator. These PDS-siRNAs would target the endogenous PDS mRNA and cause photobleaching.
- To test these predictions line #D plants were inoculated with TRV:00 or TRV:GF and monitored for photobleaching.
FIG. 2B shows that TRV:GF but not TRV:00 triggered photobleaching. Non-transgenic or 35S:GFP:NOS transgenic plants did not show any PDS silencing after infection with TRV:GF (data not shown). Spreading of targeting in line #D was confirmed by analyzing the siRNA population following infection with TRV:GF or TRV:PD which carries a part of the PDS region of the chimeric transgene. Both GF- and PD-siRNAs were present in TRV:GF- or TRV:PD-infected plants but were not in TRV:00-infected plants (FIG. 2C ). Therefore spreading of targeting in both 5′ and 3′ directions is not specific to the 35S:GFP:NOS transgene in line 16c. - To determine whether spreading of targeting depends on transgene transcription we carried out experiments after transcriptional silencing of the 35S:GFP:NOS transgene. This transcriptional silencing was induced by infection with TRV:35S, as described previously (Jones et al., 1999; Jones et al., 2001). After 21 days these silenced plants were inoculated with PVX:GF, PVX:P or PVX:00 (a PVX vector without GFP inserts). Spreading of targeting and DNA methylation was assessed 21-28 days later (
FIG. 3A ). As a control, the same PVX vectors were inoculated to TRV:00-infected plants. - As shown in
FIG. 3B (top and bottom panels) both GF- and P-siRNAs were produced in TRV:00-infected plants following PVX:GF or PVX:P inoculations. Thus, the spreading of targeting occurred with a PVX vector as for TRV vectors, and was not affected by the presence of TRV:00. In contrast, in TRV:35S-infected plants, only P-siRNAs were detected in PVX:P-infected tissue and, likewise, only GF-siRNAs were detected in PVX:GF-infected tissue (FIG. 3B , top and bottom panels). Thus, from the lack of spreading in TRV:35S-infected plants we conclude that spreading requires transcription of the target. - Spreading of GFP DNA methylation was assessed by Sau96I digestion followed by quantitative PCR (TaqMan, Applied Biosystems) of the GF and P regions of the GFP transgene. Sau96I is a methylation-sensitive restriction enzyme that cleaves within the GF and P sequences. Methylation at these Sau96I sites would prevent digestion and result in a higher level of amplifiable DNA than in non-methylated samples. Thus, the higher the amplification value, the greater the degree of DNA methylation in the PCR template.
-
FIG. 3C shows that, after PVX:GF or PVX:P inoculation of TRV:00-infected plants, amplification values for both GF and P sequences were higher than those of the non-methylated negative control (PVX:00-infected plants). Thus, when the 35S:GFP:NOS transgene is transcribed, DNA methylation is detected not only in the region targeted but also in adjacent sequences. However, the level of DNA methylation in GF was higher after PVX:GF infection than after PVX:P infection, and vice versa. In contrast, when the transgene was transcriptionally silenced by TRV:35S, methylation was only detected in the GFP region being targeted by the recombinant PVX vector (FIG. 3D ). Thus, methylation was restricted to GF after PVX:GF infection, and to P after PVX:P infection. Therefore spreading of DNA methylation, as for targeting, is dependent on transcription of the 35S:GFP:NOS transgene. - In order to determine whether SDE1/SGS2 is required for the spreading of targeting and DNA methylation we carried out experiments in wild-type or sde1/sgs2 A. thaliana carrying a 35S:GFP:NOS transgene. RNA silencing was initiated with TRV:GF and nucleic acid samples were taken at 10-15 dpi when GFP silencing was visible in both wild-type and mutant plants (data not shown). In wild-type plants, the GFP silencing was maintained throughout the life of the plant. However, as reported previously, the GFP silencing was only transient in the sde1/sgs2 background and the older plants had fully green fluorescent leaves (Dalmay et al., 2001).
-
FIG. 4A shows that, at 10-15 dpi, GFP mRNA levels were lower in silenced plants than in non-silenced mock inoculated plants and that TRV:GF RNA was more abundant in sde1/sgs2 than in the wild-type plants. The GF-siRNAs were present in both samples but were more abundant in sde1/sgs2 plants (FIG. 4B , bottom panel). This increased abundance of GF-siRNA is most likely due to the higher accumulation of TRV:GF in sde1/sgs2 plants (FIG. 4A ). From these results we conclude that SDE1/SGS2 is not necessary for siRNA production from the TRV:GF RNA. The P-siRNAs were detected in the TRV:GF-infected wild-type plants (FIG. 4B , top-panel) indicating that spreading of targeting takes place in A. thaliana as in N. benthamiana. However, P-siRNAs were not produced in the TRV:GF-infected sde1/sgs2 plants (FIG. 4B top panel). Therefore spreading of targeting is dependent on SDE1/SGS2. - GFP DNA methylation in TRV:GF-infected A. thaliana was assessed by Southern blot analysis after Sau96I digestion and hybridization with a P-specific probe.
FIG. 4C shows the organization of the 35S:GFP:NOS transgene, the location of Sau96I restriction enzyme sites and the sizes of total and relevant partial digestion products of the GFP transgene.FIG. 4D shows that, in mock-inoculated plants, only the 0.28 kb fragment (corresponding to the unmethylated DNA) could be detected. The 0.37 kb and 0.08 kb fragments of were most likely not detected because of either the low resolution of the gel or because the P probe overlapping region is too short. - In TRV:GF-infected wild-type plants the Sau96I digestion products were 0.28 kb, 0.84 kb and 1.29 kb. The 0.84 kb fragment indicates methylation in the GF region and the 1.29 kb fragment reflects methylation in both GF and P regions. In the TRV:GF-infected sde1/sgs2 plants the only fragment diagnostic of transgene methylation was 0.84 kb. From these results we conclude that spreading of DNA methylation, like spreading of targeting, is dependent on SDE1/SGS2. Results leading to the same conclusion were also generated with HaeIII digested DNA (data not shown).
- VIGS of PDS and ribulose bisphosphate carboxylase small subunit (rubisco) is unlike that of GFP. This RNA silencing of these endogenous genes is dependent on the continuous presence of the virus and the target DNA is not methylated (Jones et al., 1999; Ruiz et al., 1998; Thomas et al., 2001). Thus, VIGS of PDS and rubisco does not show the transition to the maintenance phase of RNA silencing. To assess spreading of targeting in VIGS of PDS we used the same approach as with the 35S:GFP:NOS transgene (
FIG. 1A ). First we initiated VIGS in N. benthamiana with TRV vectors carrying a fragment of the PDS gene. We then challenge-inoculated with PVX carrying a different part of the PDS gene. Spreading of targeting would have caused the plants to be resistant against the challenge inoculum. - The TRV vectors used in these experiments were TRV:PD and TRV:S which carry two contiguous non-overlapping regions of the N. benthamiana PDS cDNA. Plants infected with TRV:00 were used as a control for non-specific effects of virus inoculation. By 21 dpi, PDS silencing was observed as photobleached tissues in plants infected with both TRV:PD and TRV:S. In contrast, plants infected with TRV:00 remained non-silenced (
FIG. 6A ). The TRV-infected plants were then challenge-inoculated with PVX:PD or PVX:S (carrying the PDS fragments of TRV:PD and TRV:S respectively), and levels of viral PVX RNA were assessed four days later by northern blotting.FIG. 6B shows that, in TRV:00-infected plants, both PVX:PD and PVX:S accumulated at high levels. In TRV:PD-infected plants PVX:S accumulated at high levels. In contrast, PVX:PD accumulated at low levels as a consequence of crossprotection (Ratcliff et al., 1997; Ratcliff et al., 1999). Conversely, in TRV:S-infected plants PVX:PD accumulated at high levels and PVX:S at low levels. From these data we conclude that spreading of targeting had not occurred. Similar results were obtained when the endogenous target gene was the highly expressed rubisco gene (data not shown). - To further investigate spreading of targeting we characterized the antisense siRNA population in plants infected with the TRV vectors. As shown in
FIG. 6C (left panels), at 21 dpi, PD-siRNAs were present in samples from TRV:PD-infected plants and absent in TRV:S-silenced plants. Likewise, S-siRNAs were detected in TRV:S-infected plants but not in TRV:PD-infected plants.FIG. 6C (right panels) shows analogous results from plants infected with TRV:RU and TRV:BISCO carrying contiguous non-overlapping fragments of the rubisco cDNA. Plants infected with a TRV:RU vector only produced RU-siRNAs and plants infected with a TRV:BISCO vector only produced BISCO-siRNAs. Thus, taken together, these findings show that spreading of targeting does not occur with PDS and rubisco. - Thus simple VIGS of rubisco and PDS was different from that of GFP in that there was neither spreading nor RdDM (
FIG. 5 ; (Jones et al., 1999; Thomas et al., 2001)) and because the continued presence of the initator viral RNA was required for persistence of silencing (Dalmay et al., 2001; Ruiz et al., 1998). Thus, these characteristics confirm the link between spreading and initiator-independent maintenance of silencing. - The construct pGIIGPS carries the whole GUS gene, a fragment of sulphur gene and a fragment of the coat protein (CP) from PVX. Its construction is showed in
FIG. 7 . The cloning of the different fragments was made in a modified pGreenII 0229 vector (kindly provided by Dr. R. Hellens, JIC, Norwich, UK), which carries a gene that confers resistance to BASTA. The polylinker of pGreenII0229 was removed by digestion with SacI, blunt-ended and re-digested with Asp718. The polylinker was substituted by the 35S cassette from pJIT61 (kindly provided by P. Mullineaux, JIC, Norwich, UK), digested with EcoRV and Asp718 to produce the vector pGII61, which is now an expression vector. The GUS gene, containing an intron from ST-LS1 from potato, was amplified from plasmid pLaw3 using Expand Hi Fi DNA polymerase and the primers F5′GUS (5′TTATGTTACGTCCTGTAGAAACCC), and 3′GUS (5′TCATTGTTTGCCTCCCTGCTGC). The 2000 nt long PCR fragment was blunt ended and cloned into the HindIII blunt-ended site of pGII61 to produce the plasmid pGIIGUS. This plasmid was then digested with EcoRI and blunt ended using T4 DNA polymerase and used to clone a fragment of 742 nt from PVX CP generated by digestion of pgR106 (vector for PVX, kindly provided by Lu Rui, The Sainsbury Laboratory, Norwich, UK) with SalI and XhoI and blunt ended, producing the plasmid pGIIGP. This plasmid has a polylinker with sites for XbaI, BamHI, SmaI, XmaI and SacI where target genes can be cloned. As a target gene for spreading we introduced a fragment of sulphur gene from Arabidopsis (Kjemtrup et al., 1998). A 965 bp PCR fragment was amplified using Expand Hi Fi DNA polymerase (Boehringer) and the primers Sul1 (5′ccttggcgcgCCTTCACTCTCTTCTCCTTCC) and Sul2 (5′ccccttaattAATCTGGTCTTGAAGCTTGTCC) where the sequence in upper case corresponds to sulphur and the sequences in lower case introduce restriction site for AscI (Sul1) or PacI (Sul2). The fragment was blunt-ended and cloned into the Sac I, blunt ended site of pGIIGP, producing the plasmid pGIIGPS. The sulphur gene encodes for a magnesium chelatase involved in chlorophyll production. As a negative control, we made the same construction without the PVX CP fragment, which should not cause a silencing phenotype (pGIIGS,FIG. 8 ). This construct had the same sulphur fragment cloned into the EcoRI blunt-ended site of pGIIGUS. - Since these constructs were to be transformed into PVX/GFP amplicon Arabidopsis plants, which were already resistant to BASTA, the final constructs were moved to the vector pGreenII0029, which carried a gene for resistance to kanamycin in the T-DNA. A PCR fragment including the 35S promoter, GUS-IVS gene, Sulphur and PVX CP and 35S terminator was amplified from pGIIGPS and pGIIGS using the primers TR35S (5′ ccatatgtttaaaCCCCTACTCCAAAAATGTC) where the sequence in upper case corresponds to the 35S promoter and TR35T (5′ cccgtagtttaaacgtcgaggatATCGCATGC) where the sequences in upper case correspond to 35S terminator. The sequences in lower case in both primers include sites for PmeI restriction enzyme. The corresponding PCR fragments were digested with PmeI and cloned into pGreenII0029 to produce the final plasmids pKIIGPS as spreading construct and pKIIGS as non spreading negative control. Construction of pKIIGPS is shown in
FIG. 9 . - Results
- PVX/GFP amplicon Arabidopsis plants were transformed either with pKIIGPS or pKIIGS constructs. As sulphur gene encodes for a magnesium chelatase involved in chlorophyll production, its silencing should produce total or partial yellow plants. Seeds from primary transformation were germinated in plates with GM medium supplemented with 500 μg/ml Carbenicillin, 200 μg/ml Augmentin and 50 μg/ml Kanamycin. Several Kan resistant transformant plants were obtained for both constructs, but no yellow silencing seedlings were obtained for construct pKIIGPS. Since it was believed that Kanamycin may have been playing a role against the silenced plants, which already “suffered” because of the silencing of the sulphur gene, we plated the seeds in GM plates with no Kan selection and with sucrose as a carbon source supply to bypass the lack of chlorophyll. After about 10 days, some yellow seedlings were observed among a lawn of green non transformed plants, showing that spreading had occurred. Those plants were pricked out to new GM/sucrose plates where were kept to maximise the possibility of survival. Tests can be done to show that they carry the spreading transgene. As a negative control, C-24 wt Arabidopsis plants (the background ecotype for PVX/GFP amplicon plants) were transformed with construct pKIIGPS. Seeds from primary transformants germinated in the same conditions did not produce yellow seedlings.
- PVX/GFP amplicon and C-24 plants were also transformed with constructs based on GFP homology as a trigger for spreading. Seeds from transformed PVX/GFP amplicon plants were germinated in GM plates under Kan selection and, after one week, small white (for PDS-carrying constructs) or yellow (for sulphur-carrying constructs) seedlings were visible. Nevertheless, these plants were not viable and died before producing the first true leaves. Seeds were then plated in GM medium without Kan selection and in the presence of sucrose. In addition, plates carrying the PDS constructs were put under dim light, to prevent excess of photobleaching. After 4 weeks in growth room there were many tiny white plants in the PDS plates and some yellow plants in the sulphur plates. There were no yellow or white plants in control plates with original PVX amplicon seeds. White plants from PDS plates were pricked out to new plates. They had white cotyledons and, some of them, green tiny first true leaves. Plants were kept in the growth room under the same conditions and during this time most of them developed green leaves and shoots. Some developed white sectors and a very few stayed almost completely white and very small. PCR to amplify GFP showed that the three types of plants had acquired the spreading PDS transgene. Control plants that never showed white colour did not have the transgene either. The fact that few plants were white and most of them turned green could be accounted for by excessively strong silencing that prevented survival of the plants. The same is true for the sulphur constructs.
- As an alternative to virus-based constructs (e.g. Amplicons), it may be preferred to use as an inducer a hairpin construct carrying an inverted repeat of a fragment of the transgene e.g. GFP gene. The “spreading constructs” can be the same as the GFP/PDS and GFP/sulphur ones used in Examples 6 and 7.
- Both hairpin and spreading constructs may be put under a DEX promoter inducible by dexametasone, as well as under the 35S promoter.
- Inducer constructs were built as follows:
- As a vector for the construction of the hairpin, we used pFGC5941 (ChromDB, Arizona), which confers resistance to BASTA and drives transcription from 35S promoter, so that expression will be constitutive. A 686 nt fragment of GFP was amplified using primers GFP-1(X/A) (5′ aattcccgggcgcgccATGAAAGGAGAAGAACTTT), where the sequence in upper case corresponds to GFP and the sequence in lower case includes sites for XmaI and AscI restriction enzymes, and primer GFP-4(X/S) (5′ atattctagatttaaaTTCCGTCCTCCTTGAAAT), where the sequence in upper case corresponds to GFP and the one in lower case includes sites for XbaI and SwaI restriction enzymes. The amplified fragment (GF) was digested with SwaI and AscI and introduced into pFGC5941 previously digested with the same enzymes, to produce pssGF1. The same PCR fragment was then digested with XbaI and XmaI and introduced into pssGF1 previously digested with the same enzymes, to produce pGF/FG, where the GFP fragments are in inverted orientation respect to each other and separated by an intron already present in the original pFGC5941 vector (
FIG. 10 ). - To transfer the hairpin to a vector with an inducible promoter, pGF/FG was digested with XmaI, blunt ended with T4 DNA polymerase, and redigested with XhoI, releasing the hairpin (GF-intron-FG). The hairpin was then ligated into pTA 231 vector (kindly provided by Prof. N. H. Chua, Rockefeller Univ, New York, USA) previously digested with PacI, blunt-ended with T4 DNA polymerase and redigested with XhoI to produce pTAdsGF, where the GF hairpin is under the influence of a promoter inducible by dexametasone (
FIG. 11 ). As a negative control, the fragment GF-intron from pssGF1 was introduced into pTA231 in the same way, generating the construct pTAssGF, which should not produce any silencing. - Constructs pTAssGF and pTAdsGF were transformed into C-24, GFP and GFP/sde1 mutant plants. Seeds from primary transformation of GFP plants were germinated and selected in the presence of BASTA. Of 20 lines, 14 were green, indicating that in these lines the inducible promoter remains inactive before induction. Appropriate hairpin inducible lines are selected as a basis for subsequent transformations with different spreading constructs and to create a high thoughput system, using a cDNA library cloned into a GFP gene, for transformation and silencing any gene in Arabidopsis.
- Binary Vectors and Agrobacterium Strains
- Binary vectors and Agrobacterium strains used for rice transformation are the following:
- 1st round of transformation:
- pGF-FG: LB-MASt::bar::MASp-CaMV35Sp::GF-ChsAintl::FG::OCSt-RB (based upon pFGC5941 vector system)
- 2nd round of transformation:
- pRT104, pRT105 and pRT106 were constructed by inserting PCR products into the ndeI site of the gfp gene of pGVT1 (made available by V. Thole, John Innes Centre, UK).
- pGVT1=LB-NOSp::nptII::NOSt-CaMV35Sp::gfp::St-RB (pGreen-based vector)
- pRT104: a 356 nt fragment of the osga gene was amplified by from rice wt genomic DNA (Nipponbare) and inserted in sense orientation into the ndeI site of the gfp gene of pGVT1.
- pRT105: a 356 nt fragment of the osga gene was amplified by from rice wt genomic DNA (Nipponbare) and inserted in antisense orientation into the ndeI site of the gfp gene of pGVT1.
- pRT106: a 639 nt fragment of the wx gene was amplified by from rice wt genomic DNA (Nipponbare) and inserted in sense orientation into the ndeI site of the gfp gene of pGVT1.
- Plasmids were transformed into E. coli strain DH5 using the PEG-transformation technique and into Agrobacterium strains LBA4404 and GM3101 using a freeze-thaw technique. Agrobacterium strain harboured the following plasmids
- Strain # 38: GM3101 containing pGF-FG
- Strain # 42: LBA4404 containing pRT104 (pGreen-based) and pSa-Rep (pSoup-based).
- Strain # 44: LBA4404 containing pRT105 (pGreen-based) and pSa-Rep (pSoup-based).
- Strain # 45: LBA4404 containing pRT106 (pGreen-based) and pSa-Rep (pSoup-based).
Rice Transformation Procedures - Mature seeds of rice (Oryza sativa L.) variety Nipponbare were used for callus production. Dehusked seeds were sterilised with half strength commercial bleach for 15 min and rinsed three times with sterile distilled water. The embryos were aseptically removed under a dissecting microscope and plated onto NBm medium (macro-element N6, micro-elements B5, Fe-EDTA, 30 g l−1 sucrose, 2 mg l−1 2,4-D, 300 mg l−1 casein hydrolysate, 500 mg l−1 L-glutamine, 500 mg l−1 L-proline, 2.5 g l−1 Phytagel, pH 5.8, filter-sterilized vitamins B5 added after autoclavage) for 3 weeks in the dark at 25° C. Loose embryogenic transluscent globules (U), around 1 mm in size, were separated by rolling the callus grown from the original embryo onto the gelling agent. Globules were cultured for an additional 10 days onto fresh NBm medium (˜100 globules per plate) to produce embryogenic nodular units (ENU, Bec et. al. 1998), used as targets for transformation.
- Agrobacterium strains were grown for 2 d at 28° C. on solid MG/L medium (Garfinkel and Nester 1980) supplemented by 200 M acetosyringone, 50 mg l−1 Kanamycin (selection for pGreen- and pFGC5941-based vectors) and 10 mg l−1 tetracyclin (selection for pSoup-based vectors). Bacteria cells were scooped up from the plate, re-suspended in 20 ml of SU4 liquid medium (macro-element N6, micro-elements MS, Fe-EDTA, 10 g l−1 sucrose, 10 g l−1 mannitol, pH 5.5, without antibiotics) and shaken for 1 hour at 28° C. Culture plates containing ENUs were flooded with bacterial suspension OD=1 (600 nm) for 5 min. Liquid was removed and each ENU was picked and blotted onto sterile filter paper before being placed onto co-cultivation medium (NBm medium supplemented by 200 M acetosyringone) for 2 days in the dark at 25° C. After co-culture, ENUs were put onto selection medium (NBm medium containing 150 mg l−1 timentin plus either 5 mg l−1 phosphinotrycin (PPT, selection using bar gene) or 100 mg l−1 Geneticin (selection using nptII gene) in the dark at 25° C. L-glutamine was removed from all culture media when PPT was included. After two weeks culture, each callus (grown from an individual ENU) was split into 2 to 5 pieces. Pieces of callus were cultured for 3 additional weeks onto fresh NBm-based selection medium. The resistant calli grown from individual ENU, after 2+3 weeks selection, were or kept separated according to the separation undertaken at 2 weeks.
- Transformed plants were regenerated from resistant calli using culture media all supplemented with 50 mg l−1 Timentin and containing either 5 mg l−1 phosphinotrycin (PPT, selection using bar gene) or 100 mg l−1 Geneticin (selection using nptII gene). The resistant calli were transferred to PRm pre-regeneration medium (NBm medium without 2,4-D but with 2 mg l−1 BAP, 1 mg l−1 NAA, 5 mg l−1 ABA) for 9 days in the dark at 28° C. Calli showing clear differential growth were then transferred to regeneration medium RNm (NBm medium without 2,4-D but with 3 mg l−1 BAP, 0.5 mg l−1 NAA) for 2-3 weeks in the light at 28° C. Only one plant was regenerated from each orignal ENU to guarantee that each plant represented an independent transformation event. Plants were developed on MSR6 medium (Vain et al. 1998) for 2-3 weeks at 28° C. in the light. Transformed plants were transferred to a controlled environment room for growth to maturity. All transgenic plants produced were used in further experiments to ensure the study of randomised independent transformation events with the widest spectrum of expression for the non-selected genes.
- Genotyping and Phenotyping
- Transformed rice plants from the 1st round of transformation containing the transgenes and expressing small GF RNAs (20-30 nt) were selected using PCR analysis and Northern blots respectively. Two types of transgenic plant lines were identified: High and low production of small RNAs. T1 seeds were obtained by self-pollination of primary transformed rice (T0) plants. Analysis of plants from the 2nd round of transformation may be used to demonstrate a slender phenotype for osga silencing and no iodine staining of pollen and embryos for wx silencing.
- Inasmuch as they may be required or desired by the person skilled in the art to practice the present invention, all citations are specifically included herein by cross-reference.
- Al-Kaff, N. S., Covey, S. N., Kreike, M. M., Page, A. M., Pinder, R., and Dale, P. J. (1998). Transcriptional and post-transcriptional plant gene silencing in response to a pathogen. Science 279, 2113-2115.
- Aravin, A. A., Naumova, N. M., Tulin, A. V., Vagin, V. V., Rozovsky, Y. M., and Gvozdev, V. A. (2001). Double-stranded RNA-mediated silencing of genomic tandem repeats and transposable elements in the D-melanogaster germline. Current Biology 11, 1017-1027.
- Bernstein, E., Caudy, A. A., Hammond, S. M., and Hannon, G. J. (2001). Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366.
- Carthew, R. W. (2001). Gene silencing by double-stranded RNA. Current Opinion in Cell Biology 13, 244-248.
- Chuang, C.-H., and Meyerowitz, E. M. (2000). Specific and heritable genetic interference by double-stranded RNA in Arabidopsis thaliana. Proc. Natl. Acad. Sci. USA 97, 4985-4990.
- Cogoni, C., Irelan, J. T., Schumacher, M., Schmidhauser, T. J., Selker, E. U., and Macino, G. (1996). Transgene silencing of the Al-l gene in vegetative cells of Neurospora is mediated by a cytoplasmic effector and does not depend on DNA—DNA interactions or DNA methylation. EMBO J. 15, 3153-3163.
- Cogoni, C., and Macino, G. (1999). Gene silencing in Neurospora crassa requires a protein homologous to RNA-dependent RNA polymerase. Nature 399, 166-169.
- Cogoni, C., and Macino, G. (2000). Post-transcriptional gene silencing across kingdoms. Current Opinion in Genetics &
Development 10, 638-643. - Covey, S. N., Al-Kaff, N. S., Langara, A., and Turner, D. S. (1997). Plants combat infection by gene silencing. Nature 385, 781-782.
- Dalmay, T., Hamilton, A. J., Mueller, E., and Baulcombe, D. C. (2000a). Potato Virus X amplicons in arabidopsis mediate genetic and epigenetic gene silencing. Plant Cell 12, 369-379.
- Dalmay, T., Hamilton, A. J., Rudd, S., Angell, S., and Baulcombe, D. C. (2000b). An RNA-dependent RNA polymerase gene in Arabidopsis is required for posttranscriptional gene silencing mediated by a transgene but not by a virus. Cell 101, 543-553.
- Dalmay, T. D., Horsefield, R., Braunstein, T. H., and Baulcombe, D. C. (2001). SDE3 encodes an RNA helicase required for post-transcriptional gene silencing in Arabidopsis. EMBO Journal. 20, 2069-2078.
- Demmig-Adams, B., and Adams, W. W. (1992). Photoprotection and other responses of plants to high light stress. Annu. Rev. Plant Physiol. Plant Mol. Biol. 43, 599-626.
- Elbashir, S. M., Lendeckel, W., and Tuschl, T. (2001). RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes &
Development 15, 188-200. - Elmayan, T., and Vaucheret, H. (1996). Single copies of a 35S-driven transgene can undergo post-transcriptional silencing at each generation or can be transcriptionally inactivated in trans by a 35S silencer. Plant J. 9, 787-797.
- English, J. J., Mueller, E., and Baulcombe, D. C. (1996). Suppression of virus accumulation in transgenic plants exhibiting silencing of nuclear genes.
Plant Cell 8, 179-188. - Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811.
- Grishok, A., Tabara, H., and Mello, C. (2000). Genetic requirements for inheritance of RNAi in C. elegans. Science 287, 2494-2497.
- Hamilton, A. J., and Baulcombe, D. C. (1999). A novel species of small antisense RNA in post-transcriptional gene silencing. Science 286, 950-952.
- Hammond, S. M., Bernstein, E., Beach, D., and Hannon, G. (2000). An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cell extracts. Nature 404, 293-296.
- Horsch, R. B., Fry, J. E., Hoffmann, N. L., Eichholtz, D., Rogers, S. G., and Fraley, R. T. (1985). A simple and general method of transferring genes into plants. Science 227, 1229-1231.
- Hutvagner, G., McLachlan, J., Pasquinelli, A. E., Balint, E., Tuschl, T., and Zamore, P. D. (2001). A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834-838.
- Jensen, S., Gassama, M. P., and Heidmann, T. (1999). Taming of transposable elements by homology-dependent gene silencing.
Nature Genetics 21, 209-212. - Jones, L., Hamilton, A. J., Voinnet, O., Thomas, C. L., Maule, A. J., and Baulcombe, D. C. (1999). RNA-DNA interactions and DNA methylation in post-transcriptional gene silencing. Plant Cell 11, 2291-2302.
- Jones, L., Ratcliff, F., and Baulcombe, D. C. (2001). RNA-directed transcriptional gene silencing in plants can be inherited independently of the RNA trigger and requires Met1 for maintenance. Current Biology 11, 747-757.
- Jones, P. A., and Takai, D. (2001). The role of DNA methylation in mammalian epigenetics. Science 293, 1068-1070.
- Ketting, R. F., and Plasterk, R. H. A. (2000). A genetic link between co-suppression and RNA interference in C. elegans. Nature 404, 296-298.
- Kumagai, M. H., Donson, J., Della-Cioppa, G., Harvey, D., Hanley, K., and Grill, L. K. (1995). Cytoplasmic inhibition of carotenoid biosynthesis with virus-derived RNA. Proceedings Of The National Academy Of Sciences Of The United States Of America 92, 1679-1683.
- Lindbo, J. A., Silva-Rosales, L., Proebsting, W. M., and Dougherty, W. G. (1993). Induction of a highly specific antiviral state in transgenic plants: implications for regulation of gene expression and virus resistance.
Plant Cell 5, 1749-1759. - Matzke, M. A., Matzke, A. J. M., Pruss, G. J., and Vance, V. B. (2001). RNA-based silencing strategies in plants. Current Opinion in Genetics & Development 11, 221-227.
- Morel, J.-B., Mourrain, P., Beclin, C., and Vaucheret, H. (2000). DNA methylation and chromatin structure affect transcriptional and post-transcriptional transgene silencing in Arabidopsis.
Current Biology 10, 1591-1594. - Mourrain, P., Beclin, C., Elmayan, T., Feuerbach, F., Godon, C., Morel, J.-B., Jouette, D., Lacombe, A.-M., Nikic, S., Picault, N., Remoue, K., Sanial, M., Vo, T.-A., and Vaucheret, H. (2000). Arabidopsis SGS2 and SGS3 genes are required for posttranscriptional gene silencing and natural virus resistance. Cell 101, 533-542.
- Pal-Bhadra, M., Bhadra, U., and Birchler, J. A. (1999). Cosuppression of nonhomologous transgenes in Drosophila involves mutually related endogenous sequences. Cell 99, 35-46.
- Palauqui, J.-C., and Balzergue, S. (1999). Activation of systematic acquired silencing by localised introduction of DNA. Current Biology 9, 59-66.
- Palauqui, J.-C., Elmayan, T., Pollien, J.-M., and Vaucheret, H. (1997). Systemic acquired silencing: transgene-specific post-transcriptional silencing is transmitted by grafting from silenced stocks to non-silenced scions. EMBO Journal. 16, 4738-4745.
- Ratcliff, F., Harrison, B. D., and Baulcombe, D. C. (1997). A similarity between viral defense and gene silencing in plants. Science 276, 1558-1560.
- Ratcliff, F., MacFarlane, S., and Baulcombe, D. C. (1999). Gene silencing without DNA: RNA-mediated cross protection between viruses. Plant Cell 11, 1207-1215.
- Ratcliff, F., Martin-Hernandez, A. M., and Baulcombe, D. C. (2001). Tobacco rattle virus as a vector for analysis of gene function by silencing.
Plant Journal 25, 237-245. - Ruiz, M. T., Voinnet, O., and Baulcombe, D. C. (1998). Initiation and maintenance of virus-induced gene silencing.
Plant Cell 10, 937-946. - Schiebel, W., Haas, B., Marinkovic, S., Klanner, A., and Sanger, H. L. (1993a). RNA-directed RNA polymerase from tomato leaves. I. Purification and physical properties. The Journal of Biological Chemistry. 263, 11851-11857.
- Schiebel, W., Haas, B., Marinkovic, S., Klanner, A., and Sanger, H. L. (1993b). RNA-directed RNA polymerase from tomato leaves. II. Catalytic in vitro properties. The Journal of Biological Chemistry. 268, 11858-11867.
- Smardon, A., Spoerke, J. M., Stacey, S. C., Klein, M. E., Mackin, N., and Maine, E. M. (2000). EGO-1 is related to RNA-directed RNA polymerase and functions in germ-line development and RNA interference in C. elegans. Curr. Biol. 10, 169-178.
- Smith, N. A., Singh, S. P., Wang, M. B., Stoutjesdijk, P. A., Green, A. G., and Waterhouse, P. M. (2000). Gene expression—Total silencing by intron-spliced hairpin RNAs. Nature 407, 319-320.
- Thomas, C. L., Jones, L., Baulcombe, D. C., and Maule, A. J. (2001). Size constraints for targeting post-transcriptional gene silencing and for RNA-directed methylation in Nicotiana benthamiana using a potato virus X vector.
Plant Journal 25, 1-11. - Voinnet, O., and Baulcombe, D. C. (1997). Systemic signalling in gene silencing. Nature 389, 553.
- Voinnet, O., Vain, P., Angell, S., and Baulcombe, D. C. (1998). Systemic spread of sequence-specific transgene RNA degradation is initiated by localised introduction of ectopic promoterless DNA. Cell 95, 177-187.
- Wang, M. B., Wesley, S. V., Finnegan, E. J., Smith, N. A., and Waterhouse, P. M. (2001). Replicating satellite RNA induces sequence-specific DNA methylation and truncated transcripts in plants. RNA-a Publication of the RNA Society 7, 16-28.
- Wassenegger, M. (2000). RNA-directed DNA methylation. Plant Molecular Biology 43, 203-220.
- Waterhouse, P. M., Wang, M. B., and Lough, T. (2001). Gene silencing as an adaptive defence against viruses. Nature 411, 834-842.
- Wu-Scharf, D., Jeong, B.-r., Zhang, C., and Cerutti, H. (2000). Transgene and transposon silencing in Chlamydomonas reinhardtii by a DEAH-Box RNA helicase. Science 290, 1159-1162.
- Zamore, P. D., Tuschl, T., Sharp, P. A., and Bartel, D. P. (2000). RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101, 25-33.
-
- Bec S, Chen L, Ferriere N M, Legave T, Fauquet C, Guideroni E (1998) Comparitive histology of microprojectile-mediated gene transfer to embryonic calli in japonica rice (oryza sativa L.): influence of the structural organization of target tissues on genotype transformation ability. Plant Science 138:177-190
- Chuang, C.-H., and Meyerowitz, E. M. (2000). Specific and heritable genetic interference by double-stranded RNA in Arabidopsis thaliana. Proc. Natl. Acad. Sci. USA 97, 4985-4990.
- Garfinkel M, Nester EW (1980) Agrobacterium tumefaciens mutants affected in crown gall tumorigenesis and octopine catabolism. Journal of Bacteriology 144:732-743
- Kjemtrup, S., Sampson, K. S., Peele, C. G., Nguyen, L. V., Conkling, M. A., Thompson, W. F., and Robertson, D. (1998). Gene silencing from plant DNA carried by a geminivirus. Plant J. 14, 91-100.
- Kumagai, M. H., Donson, J., Della-Cioppa, G., Harvey, D., Hanley, K., and Grill, L. K. (1995). Cytoplasmic inhibition of carotenoid biosynthesis with virus-derived RNA. Proc. Natl. Acad. Sci. USA 92, 1679-1683.
- Peele, C., Jordan, C. V., Muangsan, N., Turnage, M., Egelkrout, E., Eagle, P., Hanley-Bowdoin, L., and Robertson, D. (2001). Silencing of a meristematic gene using geminivirus-derived vectors. Plant J. 27, 357-366.
- Ratcliff, F., Martin-Hernandez, A. M., and Baulcombe, D. C. (2001). Tobacco rattle virus as a vector for analysis of gene function by silencing. Plant J. 25, 237-245.
- Ruiz, M. T., Voinnet, O., and Baulcombe, D. C. (1998). Initiation and maintenance of virus-induced gene silencing.
Plant Cell 10, 937-946. - Smith, N. A., Singh, S. P., Wang, M. B., Stoutjesdijk, P. A., Green, A. G., and Waterhouse, P. M. (2000). Gene expression—Total silencing by intron-spliced hairpin RNAs. Nature 407, 319-320.
- Vain P, Worland B, Clarke M C, Richard G, Beavis M, Liu H, Kohli A, Leech M, Snape J W, Christou P, Atkinson H (1998) Expression of an engineered proteinase inhibitor (Oryzacystatin-IΔd86) for nematode resistance in transgenic rice plants. Theor and Appl Genet 96:266-271
- Wesley, S. V., Helliwell, C. A., Smith, N. A., Wang, M., Rouse, D. T., Liu, Q., Gooding, P. S., Singh, S. P., Abbott, D., Stoutjesdijk, P. A., Robinson, S. P., Gleave, A. P., Green, A. G., and Waterhouse, P. (2001). Construct design for efficient, effective and high-throughput gene silencing in plants. Plant J. 27, 581-590.
- Key to sequence annotation;
Upper-case plasmid backbone sequence Lower- case CaMV 35S promoter sequence UPPER-CASE UNDERLINED GUS-IVS UPPER-CASE AND BOLD PVX sequence Lower-case and bold Sulphur sequence Lower- case italics CaMV 35S terminator sequence Lower-case, bold and GFP sequences Underlined UPPER CASE ITALICS CSHA intron sequence Lower case underlined OCS 3′ terminator sequenceLower case underlined Inducible elements and BASTA and italics resistance in pTAdsGF UPPER CASE, ITALICS Pea Rubisco small subunit gene UNDERLINED terminator - 1-Sequence of pKIIGPS.
TCTTGGCAGGATATATTGTGGTGTAACGTTATCAGCTTGCATGCCGGTCGATCTAGTAACATAGATGACACCGC GCGCGATAATTTATCCTAGTTTGCGCGCTATATTTTGTTTTCTATCGCGTATTAAATGTATAATTGCGGGACTC TAATCAAAAAACCCATCTCATAAATAACGTCATGCATTACATGTTAATTATTACATGCTTAACGTAATTCAACA GAAATTATATGATAATCATCGCAAGACCGGCAACAGGATTCAATCTTAAGAAACTTTATTGCCAAATGTTTGAA CGATCTGCTTGACTCTAGCTAGAGTCCGAACCCCAGAGTCCCGCTCAGAAGAACTCGTCAAGAAGGCGATAGAA GGCGATGCGCTGCGAATCGGGAGCGGCGATACCGTAAAGCACGAGGAAGCGGTCAGCCCATTCGCCGCCAAGCT CTTCAGCAATATCACGGGTAGCCAACGCTATGTCCTGATAGCGGTCCGCCACACCCAGCCGGCCACAGTCGATG AATCCAGAAAAGCGGCCATTTTCCACCATGATATTCGGCAAGCAGGCATCGCCCTGGGTCACGACGAGATCCTC GCCGTCGGGCATCCGCGCCTTGAGCCTGGCGAACAGTTCGGCTGGCGCGAGCCCCTGATGCTCTTCGTCCAGAT CATCCTGATCGACAAGACCGGCTTCCATCCGAGTACGTCCTCGCTCGATGCGATGTTTCGCTTGGTGGTCGAAT GGGCAGGTAGCCGGATCAAGCGTATGCAGCCGCCGCATTGCATCAGCCATGATGGATACTTTCTCGGCAGGAGC AAGGTGAGATGACAGGAGATCCTGCCCCGGCACTTCGCCCAATAGCAGCCAGTCCCTTCCCGCTTCAGTGACAA CGTCGAGCACAGCTGCGCAAGGAACGCCCGTCGTGGCCAGCCACGATAGCCGCGCTGCCTCGTCTTGGAGTT CATTCAGGGCACCGGACAGGTCGGTCTTGACAAAAAGAACCGGGCGCCCCTGCGCTGACAGCCGGAACACGGCG GCATCAGAGCAGCCGATTGTCTGTTGTGCCCAGTCATAGCCGAATAGCCTCTCCACCCAAGCGGCCGGAGAACC TGCGTGCAATCCATCTTGTTCAATCATGCCTCGATCGAGTTGAGAGTGAATATGAGACTCTAATTGGATACCGA GGGGAATTTATGGAACGTCAGTGGAGCATTTTTGACAAGAAATATTTGCTAGCTGATAGTGACCTTAGGCGACT TTTGAACGCGCAATAATGGTTTCTGACGTATGTGCTTAGCTCATTAAACTCCAGAAACCCGCGGCTGAGTGGCT CCTTCAACGTTGCGGTTCTGTCAGTTCCAAACGTAAAACGGCTTGTCCCGCGTCATCGGCGGGGGTCATAACGT GACTCCCTTAATTCTCATGTATCGATAACATTAACG TTTACAATTTCGCGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCT ATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCAC GACGTTGTAAAACGACGGCCAGTGAATTGTAATACGACTCACTATAGGGCGAATTGggtacccccctactccaa aaatgtcaaagatacagtctcagaagaccaaagggctattgagacttttcaacaaagggtaatttcgggaaacc tcctc Ggattccattgcccagctatctgtcacttcatcgaaaggacagtagaaaaggaaggtggctcctacaaatgcca tcattgcga Taaaggaaaggctatcattcaagatgcctctgccgacagtggtcccaaagatggacccccacccacgaggagca tcgtgga Aaaagaagacgttccaaccacgtcttcaaagcaagtggattgatgtgacatctccactgacgtaagggatgacg cacaatccc ActatccttcgcaagacccttcctctatataaggaagttcatttcatttggagaggacagcccaagctTTATGT TACGT CCTGTAGAAACCCCAACCCGTGAAATCAAAAAACTCGACGGCCTGTGGGCATTCAGTCTGGATCGCGAAAACTG TGGAATTGATCAGCGTTGGTGGGAAAGCGCGTTACAAGAAAGCCGGGCAATTGCTGTGCCAGGCAGTTTTAACG ATCAGTTCGCCGATGCAGATATTCGTAATTATGCGGGCAACGTCTGGTATCAGCGCGAAGTCTTTATACCGAAA GGTTGGGCAGGCCAGCGTATCGTGCTGCGTTTCGATGCGGTCACTCATTACGGCAAAGTGTGGGTCAATAATCA GGAAGTGATGGAGCATCAGGGCGGCTATACGCCATTTGAAGCCGATGTCACGCCGTATGTTATTGCCGGGAAAA GTGTACGTAAGTTTCTGCTTCTACCTTTGATATATATATAATAATTATCATTAATTAGTAGTAATATAATATTT CAAATATTTTTTTCAAAATAAAAGAATGTAGTATATAGCAATTTTTCTGTAGTTTATAAGTGTGTATATTTTAA TTTATAACTTTTCTAATATATGACCAAAATTTGTTGATGTGCAGGTATCACCGTTTGTGTGAACAACGAACTGA ACTGGCAGACTATCCCGCCGGGAATGGTGATTACCGACGAAAACGGCAAGAAAAAGCAGTCTTACTTCCATGAT TTCTTTAACTATGCCGGATCATCGCAGCGTAATGCTCTACACCACGCCGAACACCTGGGTGGACGATATCACCG TGGTGACGCATGTCGCGCAAGACTGTAACCACGCGTCTGTTGACTGGCAGGTGGTGGCCAATGGTGATGTCAGC GTTGAACTGCGTGATGCGGATCAACAGGTGGTTGCAACTGGACAAGGCACTAGCGGGACTTTGCCAAGTGGGAA TCCGCACCTCTGGCAACCGGGTGAAGGTTATCTCTATGAACTGTGCGTCACAGCCAAAAGCCAGACAGAGTGTG ATATCTACCCGCTTCGCGTCGGCATCCGGTCAGTGGCAGTGAAGGGCGAACAGTTCCTGATTAACCACAAACCG TTCTACTTTACTGGCTTTGGTCGTCATGAAGATGCGGACTTACGTGGCAAAGGATTCGATAACGTGCTGATGGT GCACGACCACGCATTAATGGACTGGATTGGGGCCAACTCCTACCGTACCTCGCATTACCCTTACGCTGAAGAGA TGCTCGACTGGGCAGATGAACATGGCATCGTGGTGATTGATGAAACTGCTGCTGTCGGCTTTAACCTCTCTTTA GGCATTGGTTTCGAAGCGGGCAACAAGCCGAAAGAACTGTACAGCGAAGAGGCAGTCAACGGGGAAACTCAGCA AGCGCACTTACAGGCGATTAAAGAGCTGATAGCGCGTGACAAAAACCACCCAAGCGTGGTGATGTGGAGTATTG CCAACGAACCGGATACCCGTCCGCAAGGTGCACGGGAATATTTCGCGCCACTGGCGGAAGCAACGCGTAAACTC GACCCGACGCGTCCGATCACCTGCGTCAATGTAATGTTCTGCGACGCTCACACCGATACAATCAGCGATCTCTT TGATGTGCTGTGCCTGAACCGTTATTACGGATGGTATGTCCAAAGCGGCGATTTGGAAACGGCAGAGAAGGTAC TGGAAAAAGAACTTCTGGCCTGGCAGGAGAAACTGCATCAGCCGATTATCATCACCGAATACGGCGTGGATACG TTAGCCGGGCTGCACTCAATGTACACCGACATGTGGAGTGAAGAGTATCAGTGTGCATGGCTGGATATGTATCA CCGCGTCTTTGATCGCGTCAGCGCCGTCGTCGGTGAACAGGTATGGAATTTCGCCGATTTTGCGACCTCGCAAG GCATATTGCGCGTTGGCGGTAACAAGAAAGGGATCTTCACTCGCGACCGCAAACCGAAGTCGGCGGCTTTTCTG CTGCAAAAACGCTGGACTGGCATGAACTTCGGTGAAAAACCGCAGCAGGGAGGCAAACAATGAagctttctaga ggatcccccggggccttggcgcgccttcactctcttctccttcctcaaaa ccttcctcctcccccatttgcttcaggccaggtaaattgtttggaagcaagttaaatgcaggaatccaaataag gcca aagaagaacaggtctcgttaccatgtttcggttatgaatgtagccactgaaatcaactctactgaacaagtagt aggg aagtttgattcaaagaagagtgcgagaccggtttatccatttgcagctatagtagggcaagatgagatgaagtt atgt cttttgttgaatgttattgatccaaagattggtggtgttatgattatgggagatagaggaactggaaaatctac aactg ttagatcattagttgatctgttacctgagattaatgtagttgcaggtgacccgtataactcggatccgatagat cctgag tttatgggtgttgaagtaagagagagagttgagaaaggagagcaagttcctgttattgcgactaagattaatat ggttg atcttcctttgggtgcaacagaagatagagtttgtggaaccatcgatatcgaaaaggctttgacagaaggtgta aaag cctttgagcctggtttgttggctaaagctaatagagggattctttatgttgatgaagttaatctcttggatgat catttggtt gatgttcttttggattcagctgcttctggttggaatacggttgagagagaagggatttcgatttctcacccggc gaggttta tcttgatcggttcaggaaatccggaagaaggagagcttaggccacagcttcttgatcggtttggtatgcatgca caagt agggacggttagagatgctgatttacgggtcaagattgttgaagagagagctcgtttcgatagtaacccaaagg atttc cgtgacacttacaaaaccgagcaggacaagcttcaagaccagattaattaaggggcgaattTCGACCGCCGATA AGCTTGATAGGGCCATTGCCGATCTCAAGCCACTCTCCGTTGAACGGTTAAGTTTCCATTGATACTCGAAAGAT GTCAGCACCAGCTAGCACAACACAGCCCATAGGTCAACTACCTCAAACTACCACAAAAACTGCAGGCGCAACTC CTGCCACAGCTTCAGGCCTGTTCACCATCCCGGATGGGGATTTCTTTAGTACAGCCCGTGCCATAGTAGCCAGC AATGCTGTCGCAACAAATGAGGACCTCAGCAAGATTGAGGCTATTTGGAAGGACATGAAGGTGCCCACAGACAC TATGGCACAGGCTGCTTGGGACTTAGTCAGACACTGTGCTGATGTAGGATCATCCGCTCAAACAGAAATGATAG ATACAGGTCCCTATTCCAACGGCATCAGCAGAGCTAGACTGGCAGCAGCAATTAAAGAGGTGTGCACACTTAGG CAAAATTTTGCATGAA GTATGCTCCAGTGGTATGGAACTQGATGTTAACTAACAACAGTCCACCTGCTAACTGGCAAGCACAAGGTTTCA AGCCTGAGCACAAATTCGCTGCATTCGACTTCTTCAATGGAGTCACCAACCCAGCTGCCATCATGCCCAAAGAG GGGCTCATCCGG CCACCGTCTGAAGCTGAATGAATGCTGCCCAAACTGCTGCCTTTGTGAAGATTACAAAGGCCAGGGCACAATCCA ACGACTTTGCCAGCCTAGATGCAGCTGTCACTCGAaattcggtacgctgaaatcaccagtctctctctacaaatct atctctctctattttctccataaa ta atgtgtgagtagtttcccgataagggaaattagggttcttatagggtttcgctcatgtgttgagcatataagaaac ccttagtatg tatttgtatttgtaaaatacttctatcaataaaatttctaattcctaaaaccaaaatccagtactaaaatccagat ctcctaaagtccc tatagatctttgtcgtgaatataaaccagacacgagacgactaaacctggagcccagacgccgttcgaagctagaa gtacc gcttaggcaggaggccgttagggaaaagatgctaaggcagggttggttacgttgactcccccgtaggtttggttta aatatga tgaagtggacggaaggaaggaggaagacaaggaaggataaggttgcaggccctgtgcaaggtaagaagatggaaa tttgatagaggtacgctactatacttatactatacgctaagggaatgcttgtatttataccctataccccctaata accccttatca atttaagaaataatccgcataagcccccgcttaaaaattggtatcagagccatgaataggtctatgaccaaaactc aagag gataaaacctcaccaaaatacgaaagagttcttaactctaaagataaaagatctttcaagatcaaaactagttccc tcaca ccggagcatgcgatccagcttttgTTCCCTTTAGTGAGGGTTAATTCCGAGCTTGGCGTAATCATGGTCATAGCTG TTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGG GTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTG CCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTC ACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCA CAGAATCAGGGGATAACGCAGGAAAGAACATGAAGGCCTTGACAGGATATATTGGCGGGTAAACTAAGTCGCTGTA TGTGTTTGTTTGAGATCTCATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCG TTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAG GACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGG ATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTG TAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACT ATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGC GAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGT ATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAGAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTG GTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTT TTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATC TTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGTGTAACATTGGTCTAGTG ATTAGAAAAACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGAAA AAGCCGTTTCTGTAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATCCTGGTATCGGTCTGCG ATTCCGACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCAAAAATAAGGTTATCAAGTGAGAAATCAC CATGAGTGACGACTGAATCCGGTGAGAATGGCAAAAGTTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCAGCC ATTACGCTCGTCATCAAAATCACTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGAGACGAAAT ACGCGATCGCTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACACTGCCAGCGCATCAA CAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCTGGGATCGCAGTGGTGAGTAA CCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAGGCATAAATTCCGTCAGCCAGTTTAGTCTG ACCATCTCATCTGTAACAACATTGGCAACGCTACCTTTGCCATGTTTCAGAAACAACTCTGGCGCATCGGGCTTCC CATACAATCGGTAGATTGTCGCACCTGATTGCCCGACATTATCGCGAGCCCATTTATACCCATATAAATCAGCATC CATGTTGGAATTTAATCGCGGCCTTGAGCAAGACGTTTCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTG TTTATGTAAGCAGACAGTTTTATTGTTCATGATGATATATTTTTATCTTGTGCAATGTAACATCAGAGATTTTGAG ACACAACGTGGCTTTGTTGAATAAATCGAACTTTTGCTGAGTTGAAGGATCAGATCACGCATCTTCCCGACAACGC AGAC CGTTCCGTGGCAAAGCAAAAGTTCAAAATCACCAACTGGTCCACCTACAACAAAGCTCTCATCAACCGTGGCTC CCTCACTTTCTGGCTGGATGATGGGGCGATTCAGGCGATCCCCATCCAACAGCCCGCCGTCGAGCGGGCTTTTT TATCCCCGGAAG CCTGTGGATAGAGGGTAGTTATCCACGTGAAACCGCTAATGCCCCGCAAAGCCTTGATTCACGGGGCTTTCCGG CCCGCTCCAAAAACTATCCACGTGAAATCGCTAATCAGGGTACGTGAAATCGCTAATCGGAGTACGTGAAATCG CTAATAAGGTCA CGTGAAATCGCTAATCAAAAAGGCACGTGAGAACGCTAATAGCCCTTTCAGATCAACAGCTTGCAAACACCCCT CGCTCCGGCAAGTAGTTACAGCAAGTAGTATGTTCAATTAGCTTTTCAATTATGAATATATATATCAATTATTG GTCGCCCTTGGCTTGTGGACAATGCGCTACGCGCACCGGCTCCGCCCGTGGACAACCGCAAGCGGTTGCCCACC GTCGAGCGCCAGCGCCTTTGCCCACAACCCGGCGGCCGGCCGCAACAGATCGTTTTATAAATTTTTTTTTTTGA AAAAGAAAAAGCCCGAAAGGCGGC AACCTCTCGGGCTTCTGGATTTCCGATCCCCGGAATTAGAGA - 2-Sequence of pKIIGS. 35S Cassette with GUS and Sulphur Inserts.
ggtacccccctactccaaaaatgtcaaagatacagtctcagaagaccaaagggctattgagacttttcaacaaa gggtaatttc gggaaacctcctcggattccattgcccagctatctgtcacttcatcgaaaggacagtagaaaaggaaggtggct cctacaaat gccatcattgcgaTaaaggaaaggctatcattcaagatgcctctgccgacagtggtcccaaagatggaccccca cccacga ggagcatcgtggaaaaagaagacgttccaaccacgtcttcaaagcaagtggattgatgtgacatctccactgac gtaaggg atgacgcacaatcccActatccttcgcaagacccttcctctatataaggaagttcatttcatttggagaggaca gcccaagctT TATGTTACGTCCTGTAGAAACCCCAACCCGTGAAATCAAAAAACTCGACGGCCTGTGGGCATTCAGTCTGGATC GCGAAAACTGTGGAATTGATCAGCGTTGGTGGGAAAGCGCGTTACAAGAAAGCCGGGCAATTGCTGTGCCAGGC AGTTTTAACGATCAGTTCGCCGATGCAGATATTCGTAATTATGCGGGCAACGTCTGGTATCAGCGCGAAGTCTT TATACCGAAAGGTTGGGCAGGCCAGCGTATCGTGCTGCGTTTCGATGCGGTCACTCATTACGGCAAAGTGTGGG TCAATAATCAGGAAGTGATGGAGCATCAGGGCGGCTATACGCCATTTGAAGCCGATGTCACGCCGTATGTTATT GCCGGGAAAAGTGTACGTAAGTTTCTGCTTCTACCTTTGATATATATATAATAATTATCATTAATTAGTAGTAA TATAATATTTCAAATATTTTTTTCAAAATAAAAGAATGTAGTATATAGCAATTTTTCTGTAGTTTATAAGTGTG TATATTTTAATTTATAACTTTTCTAATATATGACCAAAATTTGTTGATGTGCAGGTATCACCGTTTGTGTGAAC AACGAACTGAACTGGCAGACTATCCCGCCGGGAATGGTGATTACCGACGAAAACGGCAAGAAAAAGCAGTCTTA CTTCCATGATTTCTTTAACTATGCCGGATCATCGCAGCGTAATGCTCTACACCACGCCGAACACCTGGGTGGAC GATATCACCGTGGTGACGCATGTCGCGCAAGACTGTAACCACGCGTCTGTTGACTGGCAGGTGGTGGCCAATGG TGATGTCAGCGTTGAACTGCGTGATGCGGATCAACAGGTGGTTGCAACTGGACAAGGCACTAGCGGGACTTTGC CAAGTGGGAATCCGCACCTCTGGCAACCGGGTGAAGGTTATCTCTATGAACTGTGCGTCACAGCCAAAAGCCAG ACAGAGTGTGATATCTACCCGCTTCGCGTCGGCATCCGGTCAGTGGCAGTGAAGGGCGAACAGTTCCTGATTAA CCACAAACCGTTCTACTTTACTGGCTTTGGTCGTCATGAAGATGCGGACTTACGTGGCAAAGGATTCGATAACG TGCTGATGGTGCACGACCACGCATTAATGGACTGGATTGGGGCCAACTCCTACCGTACCTCGCATTACCCTTAC GCTGAAGAGATGCTCGACTGGGCAGATGAACATGGCATCGTGGTGATTGATGAAACTGCTGCTGTCGGCTTTAA CCTCTCTTTAGGCATTGGTTTCGAAGCGGGCAACAAGCCGAAAGAACTGTACAGCGAAGAGGCAGTCAACGGGG AAACTCAGCAAGCGCACTTACAGGCGATTAAAGAGCTGATAGCGCGTGACAAAAACCACCCAAGCGTGGTGATG TGGAGTATTGCCAACGAACCGGATACCCGTCCGCAAGGTGCACGGGAATATTTCGCGCCACTGGCGGAAGCAAC GCGTAAACTCGACCCGACGCGTCCGATCACCTGCGTCAATGTAATGTTCTGCGACGCTCACACCGATACCATCA GCGATCTCTTTGATGTGCTGTGCCTGAACCGTTATTACGGATGGTATGTCCAAAGCGGCGATTTGGAAACGGCA GAGAAGGTACTGGAAAAAGAACTTCTGGCCTGGCAGGAGAAACTGCATCAGCCGATTATCATCACCGAATACGG CGTGGATACGTTAGCCGGGCTGCACTCAATGTACACCGACATGTGGAGTGAAGAGTATCAGTGTGCATGGCTGG ATATGTATCACCGCGTCTTTGATCGCGTCAGCGCCGTCGTCGGTGAACAGGTATGGAATTTCGCCGATTTTGCG ACCTCGCAAGGCATATTGCGCGTTGGCGGTAACAAGAAAGGGATCTTCACTCGCGACCGCAAACCGAAGTCGGC GGCTTTTCTGCTGCAAAAACGCTGGACTGGCATGAACTTCGGTGAAAAACCGCAGCAGGGAGGCAAACAATGAa gctttctagaggatcccccggggcgaattccttggcgcgccttcaatctcttctccttcctcaaaa ccttcctcctcccccatttgcttcaggccaggtaaattgtttggaagcaagttaaatgcaggaatccaaataag gcca aagaagaacaggtctcgttaccatgtttcggttatgaatgtagccactgaaatcaactctactgaacaagtagt aggg aagtttgattcaaagaagagtgcgagaccggtttatccatttgcagctatagtagggcaagatgagatgaagtt atgt cttttgttgaatgttattgatccaaagattggtggtgttatgattatgggagatagaggaactggaaaatctac aactg ttagatcattagttgatctgttacctgagattaatgtagttgcaggtgacccgtataactcggatccgatagat cctgag tttatgggtgttgaagtaagagagagagttgagaaaggagagcaagttcctgttattgcgactaagattaatat ggttg atcttcctttgggtgcaacagaagatagagtttgtggaaccatcgatatcgaaaaggctttgacagaaggtgta aaag cctttgagcctggtttgttggctaaagctaatagagggattctttatgttgatgaagttaatctcttggatgat catttggtt gatgttcttttggattcagctgcttctggttggaatacggttgagagagaagggatttcgatttctcacccggc gaggttta tcttgatcggttcaggaaatccggaagaaggagagcttaggccacagcttcttgatcggtttggtatgcatgca caagt agggacggttagagatgctgatttacgggtcaagattgttgaagagagagctcgtttcgatagtaacccaaagg atttc cgtgacacttacaaaaccgagcaggacaagcttcaagaccagattaattaaggggaattcggtacgctgaaatc acca gtctctctctacaaatctatctctctctattttctccataaataatgtgtgagtagtttcccgataagggaaat tagggttcttatagg gtttcgctcatgtgttgagcatataagaaacccttagtatgtatttgtatttgtaaaatacttctatcaataaa atttctaattccta aaaccaaaatccagtactaaaatccagatctcctaaagtccctatagatctttgtcgtgaatataaaccagaca cgagac gactaaacctggagcccagacgccgttcgaagctagaagtaccgcttaggcaggaggccgttagggaaaagatg cta aggcagggttggttacgttgactcccccgtaggtttggtttaaatatgatgaagtggacggaaggaaggaggaa gacaa ggaaggataaggttgcaggccctgtgcaaggtaagaagatggaaatttgatagaggtaagctactatacttata ctatac gctaagggaatgcttgtatttataccctataccccctaataaccccttatcaatttaagaaataatccgcataa gcccccgc ttaaaaattggtatcagagccatgaataggtctatgaccaaaactcaagaggataaaacctcaccaaaatacga aaga gttcttaactctaaagataaaagatcattcaagatcaaaactagttccctcacaccggagcatgcgatcaagct tttgTTC - 3-Sequence of pGF/FG. Showed from Promoter to Terminator.
tactccaaaaatgtcaaagatacagtctcagaagaccaaagggctattgagacttttcaacaaaggataatttc gggaaa cctcctcggattccattgcccagctatctgtcacttcatcgaaaggacagtagaaaaggaaggtggctcctaca aatgcc atcattgcgataaaggaaaggctatcattcaagatctgcctctgccgacagtggtcccaaagatggacccccac ccacga ggagcatcgtggaaaaagaagacgttccaaccacgtcttcaaagcaagtggattgatgtgacatctccactgac gtaagg gatgacgcacaatcccactatccttcgcaagacccttcctctatataaggaagttcatttcatttggagaggac acgctc gagtataagagctcatttttacaacaattaccaacaacaacaaacaacaaacaacattacaattacatttacaa ttatcc atGGCGCGCC agtaaaggagaagaacttttcactggagttgtcccaattcttgttgaattagatggtgatgtt aatgggcacaaattttctgtcagtggagagggtgaaggtgatgcaacatacggaaaacttacccttaaatttat t tgcactactggaaaactacctgttccatggccaacacttgtcactactttctcttatggtgttcaatgcttttc aagat acccagatcatatgaagcggcacgacttcttcaagagcgccatgcctgagggatacgtgcaggagaggaccat cttcttcaaggacgacgggaactacaagacacgtgctgaagtcaagtttgagggagacaccctcgtcaacagg atcgagcttaagggaatcgatttcaaggaggacggaa TTTAAATGTGTAAGAATTTCTTATGTTA CATTATTACATTCAACGTTTTATCTTAATTGGCTCTTCATTTGATTGAAATTTGACAATTATTTCTTGTTTTTT TTTTTGTCACACTCTTTTTGGGTTGGGGTGGCCGACGAATTGTGGGAAGGTAGAAAGAGGGGAGGACTTTTGTT ATACTCCATTAGTAATTACTGTTTCCGTTTCAATTTATGTGACAATATTTCCTTTTTAGTCGGTTCCAAAAGAA AATGTCAGCATTATAAACAATTTAATTTTGAAATTACAATTTTGCCATTAATAAAATGATTTACAACCACAAAA GTATCTATGAGCCTGTTTGGGTGGGCTTATAAGCAGCTTATTTTAAGTGGCTTATAAGTCAAAAAGTGACATTT TTGAGAAGTTAGAAAATCCTAACTTCTCAAAAAGTAGCTTTTAAGCCACTTATGACTTATAAGTCCAAAAATTT TTAAGTTACCAAACATATATTAATGGGTTTATAAACTTATAAAGCCACTTTTAAACTCACCCAACGGGTTCTAT GTCTCACTTTAGACTACAAATTTTAAAAGTCTTCATTTATTTCTTAATCTCCGTGGCGAGTAAACTATAACACA TAAAGTGAAACGGAGGGAATAAGATGGAGTCATAAACTAATCCAAATCTATACTCTCTCCGTTAATTTGTTTTT TAGTTTGATTTGGTACATTAATAAAACAGATTTTTCGAAGGTTATAAACACAGACAGATGTTTCCCAGCGAGCT AGCAAAATTCCAAGATTTCTGTCGAAAATTCGTGTGTTTCTAGCTAGTACTTGATGTTATCTTTAACCTTTTAG TAATTTTTTGTCCTTTTCTTTCTATTTTTCATCTTACAATGAATTATGAGCAAGTTCCTTAAGTAGCATCACAC GTGAGATGTTTTTTATGATATTGACTAAATCCAATCTTTACCATTCCTTAAAAACTACTATACAACACATGTTA ATTGATACATTGCTTAACACTGAGGTTAGAAAATTTTAGAAATTAGTTGTCCAAATGCTTTGAAATTAGAAATC TTTAATCCCTTATTTTTTTTTAAAATGTTTTTTCTCACTCCAAAGAAAGAGAAACTGACATGAAAGCTCAAAAG ATCATGAATCTTACTAACTTTGTCCAACTAAATGTACATCAGAATGTTTCTGACATGTGAAAATGAAAGCTCTT AATTTTCTTCTTTTATTTATTGAGGGTTTTTGCATGCTATGCATTCAATTTGAGTACTTTAAAGCACCTATAAA CACTTACTTACACTTGCCTTGGAGTTTATGTTTTAGTGTTTTCTTCACATCTTTTTTCGTCAATTTGCAGCTAT TGGATCCTAGGTGAGTCTAGATTTAAA ttccgtcctccttgaaatcgattccctta Agctcgatcctgttgacgagggtgtctccctcaaacttgacttcagcacgtgtcttgtagttcccgtcgtcctt gaag Aagatggtcctctcctgcacgtatccctcaggcatggcgctcttgaagaagtcgtgccgcttcatatgatctgg gta Tcttgaaaagcattgaacaccataagagaaagtagtgacaagtgttggccatggaacaggtagttttccagtag t Gcaaataaatttaagggtaagttttccgtatgttgcatcaccttcaccctctccactgacagaaaatttgtgcc catt Aacatcaccatctaattcaacaagaattgggacaactccagtgaaaagttcttctcctttact GGCGCGCCCG GGActagtccctagagtcctgtctttaatgagatatgcgagacgcctatgatcgcatgatatttgctttcaatt ctgttgtgcac Gttgtaaaaaacctgagcatgtgtagctcagatccttaccgccggtttcggttcattctaatgaatatatcacc cgttactatcgta Tttttatgaataatattctccgttcaatttactgattgtaccctactacttatatgtacaatattaaaatgaaa acaatatattgtgctgaa Taggtttatagcgacatctatgatagagcgccacaataacaaacaattgcgttttattattacaaatccaattt taaaaaaagcgg Cagaaccggtcaaacctaaaagactgattacataaatcttattcaaatttcaaaagtgccccaggggctagtat ctacgacaca Ccgagcggcgaactaataacgctcactgaagggaactccggttccccgccggcgcgcatgggtgagattccttg aagttga gtattggccgtccgctctaccgaaagttacgggcaccattcaacccggtccagcacggcggccgggtaaccgac ttgctgccccgagaattatgcagcatttttttg gtgtatgtgggccccaaatgaagtgcaggtcaaaccttgacagtgacgacaaatcgttgggcgggtccagggcg aattttg cgacaacatgtcgaggctcagcaggacctgcaggcatgcaagctt 4- Inducible promoter and hairpin GF construct in pTAdsGF gatatcgtggatccaagcttgccacgtgccgccacgtgccgccacgtgccgccacgtgcctctagaggatccat ctccac tgacgtaagggatgacgcacaatcccactatccttcgcaagacccttcctctataeaaggaagttcatttcatt tggaga ggacacgctgggatccccaaacaatggcagatccaatgaagctactgtcttctatcgaacaagcatgcgatatt tgccga cttaaaaagctcaagtgctccaaagaaaaaccgaagtgcgccaagtgtctgaagaacaactgggagtgtcgcta ctctcc caaaaccaaaaggtctccgctgactagggcacatatgacagaagtggaatcaaggctagaaagactggaacagc tatttc tactgatttttcctaggtcgagcgcccccccgaccgatgtcagcctgggggaagagctccacttagacggcgag gacgtg gcgatggcgcatgccgacgcgctagacgatttcgatctggacatgttgggggacggggattccccgggtccggg atttac cccccacgactccgccccctacggcgctctggatatggccgacttcgagtttgagcagatgtttaccgatgccc ttggaa ttgacgagtacggtggggatccaattcagcaagccactgcaggagtctcacaagacacttcggaaaatcctaac aaaaca atagttcctgctgcattaccacagctcacccctaccttggtgtcactgctggaggtgattgaacccgaggtgtt gtatgc aggatatgatagctctgttccagattcagcatggagaattatgaccacactcaacatgttaggtgggcgtcaag tgatty cagcagtgaaatgggcaaaggcgataccaggcttcagaaacttacacatggatgaccaaatgaccctgctacay tactca tggatgtttctcatggcatttgccctgggttggagatcatacagacaatcaagcggaaacctgctctgctttgc tcctga tctgattattaatgagcagagaatgtctctaccctgcatgtatgaccaatgtaaacacatgctgtttgtctcct ctgaat tacaaagattgcaggtatcctatgaagagtatctctgtatgaaaaccttactgcttctctcctcagttcctaag gaaggt ctgaagagccaagagttatttgatgagattcgaatgacttatatcaaagagctaggaaaagccatcgtcaaaag ggaagg gaactccagtcagaactggcaacggttttaccaactgacaaagcttctggactccatgcatgaggtggttgaga atctcc ttacctactgcttccagacatttttggataagaccatgagtattgaattcccagagatgttagctgaaatcatc actaat cagataccaaaatattcaaatggaaatatcaaaaagcttctgtttcatcaaaaatgactcgacctaactgagta agctag cttgttcgagtattatggcattgggaaaactgtttttcttgtaccatttgttgtgcttgtaatttactgtgttt tttatt cggttttcgctatagaactgtgaaatggaaatggatggagaagagttaatgaatgatatggtccttttgttcat tctcaa attaatattatttgttttttctcttatttgttgtgtgttgaatttgaaattataagagatatgcaaacattttg ttttga gtaaaaatgtgtcaaatcgtggcccctaatgaccgaagttaatatgaggagtaaaacactagatcccaaacaay cttgaa gcttgaaactgaaggcgggaaacgacaatctgatcatgagcggagaattaagggagtcacgttatgacccccgc cgatga cgcgggacaagccgttttacgtttggaactgacagaaccgcaacgattgaaggagccactcagccgcgggtttc tggagt ttaatgagctaagcacatacgtcagaaaccattattgcgcgttcaaaagtcgcctaaggtcactatcagctagc aaatat ttcttgtcaaaaatgctccactgacgttccataaattcccctcggtatccaattagagtctcatattcactctc aatcca aataatctgcaccggatcccctagaatgtttgaacgatctgcttgactctaggggtcatcagatttcggtgacg ggcagg accggacggggcggcaccggcaggctgaagtccagctgccagaaacccacgtcatgccagttcccgtgcttgaa gccggc cgcacgcagcatgccacggggggcatatccgagcgcctcgtgcatgcgcacgctcgggtcgttgggcagcccga tgacag cgaccacgctcttgaagccctgtgcctccagggacttcagcaggtgggtgtagagcgtggagcccagtcccgtc cgctgg tggcggggggagacgtacacggttgactcggccgtccagtcgtaggcgttgcgtgccttccagggacccgcgta ggcgat gccggcgacctcgccgtccacctcggcgacgagccagggatagcgctcccgcagacggacgaggtcgtccgtcc actcct gcggttcctgcggctcggtacggaagttgaccgtgcttgtctggatgtagtggttgacgatggtgcagaccgcc ggcaty tccgcctcggtggcacggcggatgtcggccgggcgtcgttctgggctcatggtagatccccctcgatcgagttg acgata gttcaaacatttggcaataaagtttcttaagattgaatcctgttgccggtcttgcgatgattatcatataattt ctgttg aattacgttaagcatgtaataattaacatgtaatgcatgacgttatttatgagatgggtttttatgattagagt cccgca attatacatttaatacgcgatagaaaacaaaatatagcgcgcaaactaggataaattatcgcgcgcggtgtcat ctatgt tactagatcggggaattgatcccccctcgacagcttgcatgccggtcgactctagaggatccgggtgacagccc tccgac gggtgacagccctccgacgggtgacagccctccgaattctagaggatccgggtgacagccctccgacgggtgac agccct ccgacgggtgacagccctccgaattcgagctcggtacccggggatctgtcgacctcgatcgagatcttcgcaag accctt cctctatataaggaagttcatttcatttggagaggacacgctgaagctagtcgactctagcctcgagtataaga gctcat ttttacaacaattaccaacaacaacaaacaacaaacaacattacaattacatttacaattatc catGGCGCGCC agtaaa ggagaagaacttttcactggagttgtcccaattcttgttgaattagatggtgatgttaatgggcacaaattttc tgtcag tggagagggtgaaggtgatgcaacatacggaaaacttacccttaaatttatttgcactactggaaaactacctg ttccat ggccaacacttgtcactactttctcttatggtgttcaatgcttttcaagatacccagatcatatgaagcggcac gacttc ttcaagagcgccatgcctgagggatacgtgcaggagaggaccatcttcttcaaggacgacggqaactacaagac acgtgc tgaagtcaagtttgagggagacaccctcgtcaacaggatcgagcttaagggaatcgatttcaaggaggacggaa TTTaaatGTGTAAGAATTTCTTATGTTACATTATTACATTCAACGTTTTATCTTAATTGGCTCTTCATTTGATT GAAATTTGACAATTATTTCTTGTTTTTTTTTTTGTCACACTCTTTTTGGGTTGGGGTGGCCGACGAATTGTGGG AAGGTAGAAAGAGGGGAGGACTTTTGTTATACTCCATTAGTAATTACTGTTTCCGTTTCAATTTATGTGACAAT ATTTCCTTTTTAGTCGGTTCCAAAAGAAAATGTCAGCATTATAAACAATTTAATTTTGAAATTACAATTTTGCC ATTAATAAAATGATTTACAACCACAAAAGTATCTATGAGCCTGTTTCGGTGGGCTTATAAGCAGCTTATTTTAA GTGGCTTATAAGTCAAAAAGTGACATTTTTGAGAAGTTAGAAAATCCTAACTTCTCAAAAAGTAGCTTTTAAGC CACTTATGACTTATAAGTCCAAAAATTTTTAAGTTACCAAACATATATTAATGGGTTTATAAGCTTATAAGCCA CTTTTAAGCTCACCCAAACGGGTTCTATGTCTCACTTTAGACTACAAATTTTAAAAGTCTTCATTTATTTCTTA ATCTCCGTGGCGAGTAAACTATAACACATAAAGTGAAACGGAGGGAATAAGATGGAGTCATAAACTAATCCAAA TCTATACTCTCTCCGTTAATTTGTTTTTTAGTTTGATTTGGTACATTAATAAAACAGATTTTTCGAAGGTTATA AACACAGACAGATGTTTCCCAGCGAGCTAGCAAAATTCCAAGATTTCTGTCGAAAATTCGTGTGTTTCTAGCTA GTACTTGATGTTATCTTTAACCTTTTAGTAATTTTTTGTCCTTTTCTTTCTATTTTTCATCTTACAATGAATTA TGAGCAAGTTCCTTAAGTAGCATCACACGTGAGATGTTTTTTATGATATTGACTAAATCCAATCTTTACCATTC CTTAACTAGTAAAATACAACACATGTTAATTGATACATTGCTTAACACTGAGGTTAGAAAATTTTAGAAATTAG TTGTCCAAATGCTTTGAAATTAGAAATCTTTAATCCCTTATTTTTTTTTAAAATGTTTTTTCTCACTCCAAAGA AAGAGAAACTGACATGAAAGCTCAAAAGATCATGAATCTTACTAACTTTGTGGAACTAAATGTACATCAGAATG TTTCTGACATGTGAAAATGAAA GCTCTTAATTTTCTTCTTTTATTTATTGAGGGTTTTTGCATGCTATGCATTCAATTTGAGTACTTTAAAGCACC TATAAACACTTACTTACACTTGCCTTGGAGTTTATGTTTTAGTGTTTTCTTCACATCTTTTTTGGTCAATTTGC AGGTATTGGATCCTAGGTGAGTCTAGATTTAAA ttccgtcctccttgaaatcgattcccttaagctcgatcctg ttgacgagggtgtctccc tcaaacttgacttcagcacgtgtcttgtagttcccgtcgtccttgaagaagatggtcctctcctgcacgtatcc ctcagg catggcgctcttgaagaagtcgtgccgcttcatatgatctgggtatcttgaaaagcattgaacaccataagaga aagtag tgacaagtgttggccatggaacaggtagttttccagtagtgcaaataaatttaagggtaagttttccgtatgtt gcatca ccttcaccctctccactgacagaaaatttgtgcccattaacatcaccatctaattcaacaagaattgggacaac tccagt gaaaagttcttctcctttact GGCGCGCCCGG ATTAACTAGTCGATCCGTCGACACAAAAAGCCTATACTGTAC TTAACTTGATTGCATAATTACTTGATCATAGACTCATAGTAAACTTGATTACACAGATAAGTGAAGAAACAAAC CAATTCAAGACATAACCAAAGAGAGGTGAAAGACTGTTTTATATGTCTAACATTGCACCTTAATATCACACTGT TAGTTCCTTTCTTACTTAAATTCAACCCATTAAAGTAAAAACAACAGATAATAATAATTTGAGAATGAACAAAA GGACCATATCATTTATTAACTCTTATCCATCCATTTGCATTTTGATGTCCGAAAACAAAAACTGAAAGAACACA GTAAATTACAAGCAGAACAAATGATAGAAGAAAACAGCTTTTCCAATGCCATAATACTCAAACTTAGTAGGATT CTGGTGTGTGGGCAATGAAACTGATGCATTGAACTTGACGAACGTTGTCGAAACCGATGATACGGACGAAAGCT TCGAGAATTC -
Claims (47)
1. A method of silencing a target gene in an organism, which method comprises the steps of:
(a) providing a recombinant DNA construct including an expression cassette comprising:
(i) a promoter, operably linked to,
(ii) a chimeric nucleotide sequence encoding all or part of the target gene and a transgene,
(b) transforming the organism with said DNA construct such that the expression cassette is inserted into the genome, and
(c) initiating post transcriptional gene silencing (PTGS) of said transgene in said organism,
whereby initiation of PTGS of the transgene causes silencing of the target gene in the organism.
2. A method as claimed in claim 1 wherein the target gene is an endogenous gene and whereby PTGS of the transgene spreads in trans to silence said target gene.
3. A method as claimed in claim 1 wherein the chimeric nucleotide sequence includes at least the initiating ATG codon of the target gene.
4. A method as claimed in claim 1 wherein the sequence encoding all or part of the target gene is inserted within the sequence encoding all or part of the transgene.
5. A method as claimed in claim 1 wherein PTGS of the transgene in the organism is initiated at step (c) by introducing into the organism a second nucleic acid construct which includes sequence corresponding to the transgene sequence.
6. A method as claimed in claim 5 wherein the constructs of step (a) and step (c) each comprise an inducible promoter.
7. A method as claimed claim 1 wherein PTGS of the transgene in the organism is initiated at step (c) by introducing into the organism a virus, or sequence derived therefrom, carrying all or part of the transgene sequence.
8. A method as claimed in claim 1 wherein PTGS of the transgene in the organism is initiated at step (c) by introducing into the organism a hairpin construct carrying an inverted repeat of all or part of the transgene sequence.
9. A method as claimed in claim 1 wherein PTGS of the transgene is extant in the organism prior to transformation with the recombinant DNA construct.
10. A method as claimed in claim 9 , which method comprises the steps of:
(a) providing or selecting an organism which has been transformed with a transgene which has been subject to PTGS,
(b) providing a recombinant DNA construct including an expression cassette comprising:
(i) a promoter, operably linked to,
(ii) a chimeric nucleotide sequence encoding all or part of the target gene and a transgene,
(c) transforming the organism with said DNA construct such that the expression cassette is inserted into the genome.
11. A method as claimed in preceding claim 1 wherein the organism is a plant.
12. A method as claimed in claim 11 wherein the recombinant DNA construct including an expression cassette comprising:
(i) a promoter, operably linked to,
(ii) a chimeric nucleotide sequence encoding all or part of the target gene and a transgene,
further includes border sequences situated around the expression cassette capable of being inserted into a plant genome.
13. A recombinant DNA construct including an expression cassette comprising:
(i) a promoter, operably linked to
(ii) a chimeric nucleotide sequence encoding all or part of a target gene endogenous to a plant, and a transgene,
the construct further comprising
(iii) border sequences situated around said expression cassette, capable of being inserted into a plant genome.
14. A construct as claimed in claim 13 wherein the chimeric nucleotide sequence includes at least the initiating ATG codon of the target gene.
15. A construct as claimed in claim 13 wherein the sequence encoding all or part of the target gene is inserted within the sequence encoding all or part of the transgene.
16. A construct as claimed in claim 13 wherein the transgene is GFP or GUS.
17. A construct as claimed in claim 13 wherein the target gene is associated with a trait in the plant.
18. A composition comprising a plurality of recombinant DNA constructs wherein said DNA constructs include an expression cassette comprising:
(i) a promoter, operably linked to
(ii) a chimeric nucleotide sequence encoding all or part of a target gene endogenous to a plant, and a transgene, said target gene sequence optionally being inserted within the sequence encoding part or all of the transgene and optionally being associated with a trait in the plant,
the construct further comprising
(iii) border sequences situated around said expression cassette, capable of being inserted into a plant genome, said chimeric nucleotide sequence optionally including the initiating ATG codon of the target gene, wherein each construct includes a different target gene from the same plant.
19. A composition as claimed in claim 18 wherein each construct includes a target gene from the same cDNA library.
20. A method which comprises the step of introducing at least one DNA construct including an expression cassette comprising:
(i) a promoter, operably linked to
(ii) a chimeric nucleotide sequence encoding all or part of a target gene endogenous to a plant, and a transgene, said target gene sequence optionally being inserted within the sequence encoding part or all of the transgene and optionally being associated with a trait in the plant,
the construct further comprising
(iii) border sequences situated around said expression cassette, capable of being inserted into a plant genome, said chimeric nucleotide sequence optionally including the initiating ATG codon of the target gene into a plant cell, and causing or allowing recombination between the construct and the plant cell genome such as to introduce the expression cassette into the genome.
21. A method as claimed in claim 20 wherein said plant cell is a recombinant plant cell transformed with a second DNA construct capable of triggering PTGS of the transgene, said second construct optionally including an inducible promoter.
22. A method as claimed in claim 21 wherein said second DNA construct capable of triggering PTGS of the transgene comprises an expression cassette comprising (i) a promoter, operably linked to (ii) DNA for transcription in a plant cell of an RNA molecule that includes (I) plant virus sequences that confer on the RNA molecule the ability to replicate in the cytoplasm of the plant cell following transcription (II) a targeting sequence corresponding to the transgene.
23. A method as claimed in claim 21 wherein said second DNA construct capable of triggering PTGS of the transgene comprises a hairpin construct carrying an inverted repeat of all or part of the transgene sequence.
24. A method as claimed in claim 21 wherein the triggering of the PTGS of the transgene is controlled by an inducible promoter.
25. A plant cell obtainable by the method of claim 20 .
26. A method for producing a transgenic plant, which method comprises the steps of:
(a) performing a method as claimed in claim 25 ,
(b) regenerating a plant from the transformed plant cell.
27. A transgenic plant which is obtainable by the method of claim 26 , or which is a clone, or selfed or hybrid progeny or other descendant of said transgenic plant.
28. A method of silencing a target gene in a plant, which method comprises the steps of:
(a) providing a plant as claimed in claim 27 ,
(b) initiating PTGS of said transgene in the plant.
29. A method as claimed in claim 28 wherein a plurality of plants are provided each containing a different target gene, and PTGS is initiated in each.
30. A method a silencing a target gene in a plant, which method comprises the steps of:
(a) providing a first DNA construct which includes an expression cassette comprising:
(i) a promoter, operably linked to
(ii) a chimeric nucleotide sequence encoding all or part of a target gene endogenous to a plant, and a transgene, said target gene sequence optionally being inserted within the sequence encoding part or all of the transgene and optionally being associated with a trait in the plant,
the construct further comprising
(iii) border sequences situated around said expression cassette, capable of being inserted into a plant genome, said chimeric nucleotide sequence optionally including the initiating ATG codon of the target gene,
(b) providing a second DNA construct including an expression cassette comprising (i) a promoter, operably linked to (ii) DNA for transcription in a plant cell of an RNA molecule that includes (I) plant virus sequences that confer on the RNA molecule the ability to replicate in the cytoplasm of a plant cell following transcription (II) a targeting sequence corresponding to the transgene,
(c) transforming the organism with said DNA constructs such that the expression cassettes are inserted into the genome, and
optionally
(d) causing or permitting transcription of the expression cassettes such as to cause silencing of the target gene in an organism.
31. A method as claimed in claim 28 wherein the, or each plant phenotype is observed after the target gene is silenced.
32. A method as claimed in claim 31 wherein the, or each observation contrasted with a plant wherein the target gene is being expressed.
33. A method of characterizing a target gene comprising the steps of:
(a) silencing the target gene in a part or at a certain development stage of the plant by use of a method of claim 28 ,
(b) observing the phenotype of the part of the plant in which, or when, the target gene has been silenced.
34. A method as claimed in claim 28 further comprising the step of amplifying the silenced target gene sequence from the expression cassette in the transformed plant.
35. A method as claimed in claim 2 wherein the chimeric nucleotide sequence includes at least the initiating ATG codon of the target gene.
36. A construct as claimed in claim 14 wherein the sequence encoding all or part of the target gene is inserted within the sequence encoding all or part of the trans gene.
37. A plant cell obtainable by the method of claim 21 .
38. A plant cell obtainable by the method of claim 22 .
39. A plant cell obtainable by the method of claim 23 .
40. A method for producing a transgenic plant, which method comprises the steps of:
(a) performing a method as claimed in claim 21 ,
(b) regenerating a plant from the transformed plant cell.
41. A method for producing a transgenic plant, which hod comprises the steps of:
(a) performing a method as claimed in claim 22 ,
(b) regenerating a plant from the transformed plant cell.
42. A method for producing a transgenic plant, which method comprises the steps of:
(a) performing a method as claimed in claim 23 ,
(b) regenerating a plant from the transformed plant cell.
43. A method as claimed in claim 29 wherein the, or each plant phenotype is observed after the target gene is silenced.
44. A method as claimed in claim 30 wherein the, or each plant phenotype is observed after the target gene is silenced.
45. A method of characterizing a target gene comprising the steps of:
(a) silencing the target gene in a part or at a certain development stage of the plant by use of a method of claim 30
(b) observing the phenotype of the part of the plant in which, or when, the target gene has been silenced.
46. A method of characterizing a target gene comprising steps of:
(a) silencing the target gene in a part or at a certain development stage of the plant by use of a method of claim 31
(b) observing the phenotype of the part of the plant in which, or when, the target gene has been silenced.
47. A method of characterizing a target gene comprising the steps of:
(a) silencing the target gene in a part or at a certain development stage of the plant by use of a method of claim 32
(b) observing the phenotype of the part of the plant in which, or when, the target gene has been silenced.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB01297548 | 2001-12-12 | ||
| GB0129754A GB0129754D0 (en) | 2001-12-12 | 2001-12-12 | Methods and means for gene silencing |
| GB0200098A GB0200098D0 (en) | 2002-01-03 | 2002-01-03 | Methods and means for gene silencing |
| GB02000982 | 2002-01-03 | ||
| PCT/GB2002/005505 WO2003050288A1 (en) | 2001-12-12 | 2002-12-05 | Methods and means for gene silencing in plants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20050214263A1 true US20050214263A1 (en) | 2005-09-29 |
Family
ID=26246862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/498,660 Abandoned US20050214263A1 (en) | 2001-12-12 | 2002-12-05 | Methods and means for gene silencing in plants |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20050214263A1 (en) |
| EP (1) | EP1456389A1 (en) |
| AU (1) | AU2002347343A1 (en) |
| WO (1) | WO2003050288A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050120414A1 (en) * | 2002-01-29 | 2005-06-02 | Paul Diamond | Regulation of polynucleic acid activity and expression |
| US20070039071A1 (en) * | 2005-06-17 | 2007-02-15 | Arborgen, Llc | Cell signaling genes and related methods |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1507009T3 (en) * | 2002-05-22 | 2010-04-06 | Japan Tobacco Inc | Gene-silencing vector and gene-silencing method for its use |
| JP4842834B2 (en) * | 2003-12-09 | 2011-12-21 | ノボザイムス,インコーポレイティド | Method for eliminating or reducing gene expression in filamentous strains |
| US20090055963A1 (en) * | 2004-04-12 | 2009-02-26 | Scottish Crop Research Institute | Systemic gene silencing in plants |
| CN101652479A (en) | 2006-12-21 | 2010-02-17 | 诺维信股份有限公司 | Methods for reducing or eliminating gene expression in filamentous fungal strains by transitive RNA interference |
| EP2885409A1 (en) | 2012-08-17 | 2015-06-24 | Novozymes A/S | Methods for co-silencing expression of genes in filamentous fungal strains and uses thereof |
| CN103146736A (en) * | 2013-03-28 | 2013-06-12 | 福建农林大学 | Construction and application of plant expression carrier pGII0229-GUS |
| CN116121442B (en) * | 2023-02-07 | 2024-07-05 | 宝清北方水稻研究中心 | InDel molecular marker SG2-InDel of rice grain type QTL, reagent, kit and application thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9703146D0 (en) * | 1997-02-14 | 1997-04-02 | Innes John Centre Innov Ltd | Methods and means for gene silencing in transgenic plants |
| GB9720148D0 (en) * | 1997-09-22 | 1997-11-26 | Innes John Centre Innov Ltd | Gene silencing materials and methods |
| WO2002000894A2 (en) * | 2000-06-30 | 2002-01-03 | Cropdesign N.V. | Gene silencing vector |
-
2002
- 2002-12-05 AU AU2002347343A patent/AU2002347343A1/en not_active Abandoned
- 2002-12-05 WO PCT/GB2002/005505 patent/WO2003050288A1/en not_active Ceased
- 2002-12-05 EP EP02783279A patent/EP1456389A1/en not_active Withdrawn
- 2002-12-05 US US10/498,660 patent/US20050214263A1/en not_active Abandoned
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050120414A1 (en) * | 2002-01-29 | 2005-06-02 | Paul Diamond | Regulation of polynucleic acid activity and expression |
| US20070039071A1 (en) * | 2005-06-17 | 2007-02-15 | Arborgen, Llc | Cell signaling genes and related methods |
| US7723110B2 (en) | 2005-06-17 | 2010-05-25 | Arborgen, Llc | Plant cell signaling genes |
| US20110088126A1 (en) * | 2005-06-17 | 2011-04-14 | Arborgen, Llc | Cell signaling genes and related methods |
| US8053237B2 (en) | 2005-06-17 | 2011-11-08 | Arborgen Inc. | Plant cell signaling genes |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1456389A1 (en) | 2004-09-15 |
| WO2003050288A1 (en) | 2003-06-19 |
| AU2002347343A1 (en) | 2003-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6531647B1 (en) | Gene silencing methods | |
| Andrieu et al. | An in planta, Agrobacterium-mediated transient gene expression method for inducing gene silencing in rice (Oryza sativa L.) leaves | |
| Pflieger et al. | Efficient virus‐induced gene silencing in Arabidopsis using a ‘one‐step’TYMV‐derived vector | |
| CA2390152C (en) | Enhanced transgene expression by co-expression with a suppressor of post-transcriptional gene silencing (ptgs) | |
| Jelly et al. | Transient expression of artificial microRNAs targeting Grapevine fanleaf virus and evidence for RNA silencing in grapevine somatic embryos | |
| Levin et al. | Methods of double-stranded RNA-mediated gene inactivation in Arabidopsis and their use to define an essential gene in methionine biosynthesis | |
| US20150159157A1 (en) | MicroRNAs | |
| CA2620387A1 (en) | Methods for controlling gene expression using ta-sirna | |
| Kumar et al. | Optimization of T-DNA configuration with UBIQUITIN10 promoters and tRNA–sgRNA complexes promotes highly efficient genome editing in allotetraploid tobacco | |
| Golenberg et al. | Development of a gene silencing DNA vector derived from a broad host range geminivirus | |
| US20050214263A1 (en) | Methods and means for gene silencing in plants | |
| Canto et al. | Generation of siRNAs by T-DNA sequences does not require active transcription or homology to sequences in the plant | |
| Misra et al. | Virus-induced gene silencing in sweet basil (Ocimum basilicum) | |
| CA2297616A1 (en) | Viral vectors | |
| US20040078844A1 (en) | Methods and means for gene silencing | |
| Hewezi et al. | Local infiltration of high‐and low‐molecular‐weight RNA from silenced sunflower (Helianthus annuus L.) plants triggers post‐transcriptional gene silencing in non‐silenced plants | |
| WO2014039330A1 (en) | Transcriptional gene silencing of endogenes in plants | |
| Yin et al. | RNAi in transgenic plants | |
| Doran et al. | RNA interference: methods for plants and animals | |
| Krishnamurthy | Post-transcriptional gene silencing (PTGS) of tomato leaf curl virus (ToLCV) in tomato | |
| Baskar et al. | New-Generation Vectors for Plant Transgenics: Methods and Applications | |
| Carneiro et al. | Maize transformation to obtain plants tolerant to viruses by RNAi technology | |
| Thomson | Genetic engineering of plants | |
| Davey et al. | The genetic transformation of rice and | |
| Sarkar | Suppressor activity analysis of Tomato leaf curl New Delhi virus gene (s) and development of RNAi construct to evaluate their efficacy in inhibiting the virus. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: PLANT BIOSCIENCE LIMITED, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VAISTIJ, FABIAN;VOINNET, OLIVIER;BAULCOMBE, DAVID CHARLES;REEL/FRAME:016002/0858;SIGNING DATES FROM 20050223 TO 20050316 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |